<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Proteome Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Proteome Res</journal-id><journal-id journal-id-type="publisher-id">pr</journal-id><journal-id journal-id-type="coden">jprobs</journal-id><journal-title-group><journal-title>Journal of Proteome Research</journal-title></journal-title-group><issn pub-type="ppub">1535-3893</issn><issn pub-type="epub">1535-3907</issn><publisher><publisher-name>American ChemicalSociety</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4059257</article-id><article-id pub-id-type="doi">10.1021/pr401169d</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Functional Annotation of Proteome
Encoded by Human
Chromosome 22</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Pinto</surname><given-names>Sneha
M.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Manda</surname><given-names>Srikanth S.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Kim</surname><given-names>Min-Sik</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Taylor</surname><given-names>KyOnese</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Selvan</surname><given-names>Lakshmi Dhevi Nagarajha</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff6" ref-type="aff">#</xref><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Balakrishnan</surname><given-names>Lavanya</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff7" ref-type="aff">&#x025a1;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Subbannayya</surname><given-names>Tejaswini</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Yan</surname><given-names>Fangfei</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Prasad</surname><given-names>T. S.
Keshava</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff8" ref-type="aff">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Gowda</surname><given-names>Harsha</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath11"><name><surname>Lee</surname><given-names>Charles</given-names></name><xref rid="aff9" ref-type="aff">&#x025b3;</xref></contrib><contrib contrib-type="author" id="ath12"><name><surname>Hancock</surname><given-names>William S.</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath13"><name><surname>Pandey</surname><given-names>Akhilesh</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff10" ref-type="aff">&#x025bd;</xref><xref rid="aff11" ref-type="aff">&#x025cf;</xref><xref rid="aff12" ref-type="aff">&#x025a0;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Institute
of Bioinformatics, <institution>International Tech Park</institution>, Bangalore, Karnataka 560066, <country>India</country></aff><aff id="aff2"><label>&#x02021;</label>McKusick-Nathans
Institute of Genetic Medicine, <institution>Johns Hopkins
University School of Medicine</institution>, Baltimore, Maryland 21205, <country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label><institution>Manipal
University</institution>, Madhav Nagar, Manipal, Karnataka 576104, <country>India</country></aff><aff id="aff4"><label>&#x02225;</label>Centre
for Bioinformatics, School of Life Sciences, <institution>Pondicherry University</institution>, Puducherry 605014, <country>India</country></aff><aff id="aff5"><label>&#x022a5;</label>Barnett
Institute and Department of Chemistry and Chemical Biology, <institution>Northeastern University</institution>, Boston, Massachusetts 02115, <country>United States</country></aff><aff id="aff6"><label>#</label>School of
Biotechnology, <institution>Amrita Vishwa Vidyapeetham</institution>, Kollam 690525, <country>India</country></aff><aff id="aff7"><label>&#x025a1;</label>Department
of Biotechnology, <institution>Kuvempu University</institution>, Shimoga, Karnataka 577451, <country>India</country></aff><aff id="aff8"><label>&#x025cb;</label>IOB-NIMHANS
Proteomics and Bioinformatics Laboratory, Neurobiology Research Centre, <institution>National Institute of Mental Health and Neurosciences</institution>, Bangalore 560029, <country>India</country></aff><aff id="aff9"><label>&#x025b3;</label>Department
of Pathology, <institution>Brigham and Women&#x02019;s
Hospital</institution>, Boston, Massachusetts 02115, <country>United States</country></aff><aff id="aff10"><label>&#x025bd;</label>Department
of Biological Chemistry, <institution>Johns Hopkins University
School of Medicine</institution>, Baltimore, Maryland 21205, <country>United States</country></aff><aff id="aff11"><label>&#x025cf;</label>The
Sol Goldman Pancreatic Cancer Research Center, Department of Pathology, <institution>Johns Hopkins University School of Medicine</institution>, Baltimore, Maryland 21205, <country>United States</country></aff><aff id="aff12"><label>&#x025a0;</label>Department
of Oncology, <institution>Johns Hopkins University School
of Medicine</institution>, Baltimore, Maryland 21205, <country>United
States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>pandey@jhmi.edu</email>. Fax: <fax>(410)-502-7544</fax>. Tel.: <phone>(410)-502-6662</phone>.</corresp></author-notes><pub-date pub-type="pmc-release"><day>26</day><month>03</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>26</day><month>03</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>06</day><month>06</month><year>2014</year></pub-date><volume>13</volume><issue>6</issue><fpage>2749</fpage><lpage>2760</lpage><history><date date-type="received"><day>26</day><month>11</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 American Chemical Society</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American Chemical Society</copyright-holder></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0007" id="ab-tgr1"/></p><p>As
part of the chromosome-centric human proteome project (C-HPP)
initiative, we report our progress on the annotation of chromosome 22.
Chromosome 22, spanning 51 million base pairs, was the first chromosome
to be sequenced. Gene dosage alterations on this chromosome have been
shown to be associated with a number of congenital anomalies. In addition,
several rare but aggressive tumors have been associated with this
chromosome. A number of important gene families including immunoglobulin
lambda locus, Crystallin beta family, and APOBEC gene family are located
on this chromosome. On the basis of proteomic profiling of 30 histologically
normal tissues and cells using high-resolution mass spectrometry,
we show protein evidence of 367 genes on chromosome 22. Importantly,
this includes 47 proteins, which are currently annotated as &#x0201c;missing&#x0201d;
proteins. We also confirmed the translation start sites of 120 chromosome 22-encoded
proteins. Employing a comprehensive proteogenomics analysis pipeline,
we provide evidence of novel coding regions on this chromosome which
include upstream ORFs and novel exons in addition to correcting existing
gene structures. We describe tissue-wise expression of the proteins
and the distribution of gene families on this chromosome. These data
have been deposited to ProteomeXchange with the identifier PXD000561.</p></abstract><kwd-group><kwd>human proteome</kwd><kwd>&#x0201c;missing&#x0201d; proteins</kwd><kwd>genome annotation</kwd><kwd>uORF</kwd></kwd-group><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>pr401169d</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>pr-2013-01169d</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>With the near completion of the human
genome project, there has
been a continued effort to characterize the function of proteins involved
in cellular processes. The chromosome-centric human proteome project
(C-HPP) initiative led by the Human Proteome Organization (HUPO) attempts
to map and annotate all of the estimated 20&#x02009;300 human protein
coding genes across each chromosome.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> The
major goal of the C-HPP is to identify and functionally characterize
at least one protein product encoded by each gene with a major emphasis
on identifying 20% of the proteome that currently lacks proteomic
evidence.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Several groups have adopted
a chromosome and are employing mass spectrometry to identify and characterize
the proteome encoded.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> In addition to mass spectrometry-based analysis,
several other strategies including antibody-based detection are being
employed.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p><p>To enable characterization
of the entire proteome, several challenges
need to be overcome. A majority of the proteins that currently lack
evidence are likely to have tissue/cell-restricted expression, may
be expressed at certain stages of development, or are present in very
low abundance. It is becoming more apparent that at least some of
the current annotations of the human genome are erroneous, for example,
incorrectly annotated translation start sites and missed exons. The
global C-HPP initiative of allocating individual chromosomes to teams
around the world to identify proteins encoded by genes across all
chromosomes will help address these issues. The knowledge base and
the technical resources that would be generated will lead the community
to apply these findings to a broad array of biomedical problems. In
this regard, our team has focused on the annotation of chromosome
22.</p><p>Chromosome 22 was the first human chromosome to be fully
sequenced,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> and it is the second smallest
human autosome,
spanning about 51 million base pairs. It accounts for &#x0223c;1.8%
of the genomic DNA.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> NCBI annotation release
104 lists a total of 884 genes, of which 442 are annotated as protein
coding genes. A number of different genetic alterations associated
with various diseases and genetic abnormalities on chromosome 22 have
been reported. These include some of the well-known as well as rare
disorders such as cat eye syndrome, which is caused by extra copies
of the proximal region of chromosome 22q,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> DiGeorge syndrome,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> velocardiofacial
syndrome (VCFS),<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> and 22q13.3 deletion
syndrome<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> among others. In addition,
chromosome 22 is also reported in the formation of the Philadelphia
chromosome by reciprocal translocation between chromosome 9 and 22,
generating the BCR-ABL oncogene which is found in 95% of chronic myeloid
leukemia patients and 25&#x02013;30% of acute lymphoblastic leukemia
patients.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup></p><p>In our previous study,
we carried out deep proteomic profiling
of 30 different histologically normal tissues and hematopoietic cells,
thereby generating a draft map of the human proteome.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Here, we describe a detailed annotation of the chromosome 22-encoded
proteome. Upon mapping our proteomics data to chromosome 22, we identified
protein products encoded by 367 genes, including 47 which have been
reported to be missing based on C-HPP criteria.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> We also confirm the translation start site for 120 proteins.
Tissue-wise expression of several disease-related genes and gene families
that are clustered on this chromosome is reported. Finally, employing
our proteogenomics strategy, we provide translation evidence for several
novel coding regions such as upstream ORFs and novel exons in addition
to correction of existing gene structures.</p></sec><sec sec-type="materials|methods" id="sec2"><title>Materials and Methods</title><sec id="sec2.1"><title>Sample
Preparation and Fractionation</title><p>Histologically
normal human organs, fetal tissues, and hematopoietic cells were procured
after obtaining institutional ethical clearance. The tissues/cells
were lysed in lysis buffer containing 4% SDS, 100 mM DTT, and 100
mM Tris pH 7.5, and were homogenized, sonicated, heated for 10&#x02013;15
min at 75 &#x000b0;C, cooled, and centrifuged at 2000 rpm for 10 min.
The protein concentration of the cleared lysate was estimated using
BCA assay, and equal amounts from each of the donors was pooled for
further fractionation.</p><p>Proteins from SDS lysates were separated
on SDS-PAGE, and in-gel digestion was carried out as described earlier.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Briefly, the protein bands were destained, reduced,
alkylated, and subjected to in-gel digestion using trypsin. The peptides
were extracted, vacuum-dried, and stored at &#x02212;80 &#x000b0;C until
further analysis.</p><p>Four hundred micrograms of proteins from each sample was
subjected to in-solution
trypsin digestion following reduction and alkylation with DTT and
IAA, respectively. The peptide digests were then desalted using Sep-Pak
C<sub>18</sub> columns (Waters Corporation, Milford, MA) and lyophilized.
The lyophilized samples were reconstituted in bRPLC solvent A (10
mM TEABC, pH 8.5) and loaded on an XBridge C<sub>18</sub>, 5 &#x003bc;m
250 &#x000d7; 4.6 mm column (Waters, Milford, MA). The peptide digest
was resolved using a gradient of 0 to 100% solvent B (10 mM TEABC
in acetonitrile, pH 8.5) in 50 min. The total fractionation time was
60 min. Ninety-six fractions were collected which were then concatenated
to 24 fractions, vacuum-dried, and stored at &#x02212;80 until further
LC-MS/MS analysis.</p></sec><sec id="sec2.2"><title>LC-MS/MS Analysis</title><p>Peptide samples
from in-gel digestion
and bRPLC fractionation were analyzed on LTQ-Orbitrap Velos and LTQ-Orbitrap
Elite mass spectrometers (Thermo Electron, Bremen, Germany) interfaced
with an Easy-nLC II nanoflow liquid chromatography system (Thermo
Scientific, Odense, Southern Denmark). The peptide digests were reconstituted
in 0.1% formic acid and loaded onto a trap column (75 &#x003bc;m &#x000d7;
2 cm) packed in-house with Magic C<sub>18</sub> AQ (Michrom Bioresources,
Inc., Auburn, CA) at a flow rate of 5 &#x003bc;L/min with solvent A.
Peptides were resolved on an analytical column (75 &#x003bc;m &#x000d7;
10 cm) at a flow rate of 350 nL/min using a linear gradient of 7&#x02013;30%
solvent B (0.1% formic acid in 95% acetonitrile) over 60 min. Data-dependent
acquisition with full scans in the 350&#x02013;1800 <italic>m</italic>/<italic>z</italic> range were carried out using an Orbitrap mass
analyzer at a mass resolution of 60&#x02009;000 in Velos and 120&#x02009;000
in Elite at 400 <italic>m</italic>/<italic>z</italic>, respectively.
Twenty of the most intense precursor ions from a survey scan were
selected for MS/MS and were fragmented using higher-energy collision dissociation
(HCD) with 35% normalized collision energy and detected at a mass
resolution of 15&#x02009;000 and 30&#x02009;000 at 400 <italic>m</italic>/<italic>z</italic> in Velos and Elite, respectively. Dynamic exclusion
was set for 30 s with a 10 ppm mass window.</p></sec><sec id="sec2.3"><title>Proteomic Data Analysis</title><p>Mass spectrometry data obtained
from all LC-MS/MS analysis were searched against Human RefSeq50 database
(containing 33&#x02009;833 entries along with common contaminants)
using Sequest and Mascot (version 2.2) search algorithms through Proteome
Discoverer 1.3 (Thermo Scientific, Bremen, Germany). Enzyme specificity
was set as trypsin with maximum of two missed cleavages allowed. The
minimum peptide length was specified as six amino acids. Carbamidomethylation
of cysteine was specified as fixed modification and oxidation of methionine,
acetylation of protein N-termini and cyclization of N-terminal glutamine
were included as variable modifications. The peptide and fragment
mass tolerance was set to 10 ppm and 0.05 Da for fragment ions. The
data were also searched against a decoy database, and the results
were used to estimate <italic>q</italic> values using the Percolator
algorithm<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> within Proteome Discoverer.
Peptides were considered identified at a <italic>q</italic> value
&#x0003c;0.01 and used for further analysis.</p></sec><sec id="sec2.4"><title>Identification of Novel
Peptides Using Alternative Databases
Searches</title><p>To enable identification of novel peptides and correction
of existing gene annotations in the human genome, five alternative
databases were used. These databases were generated using in-house
python scripts for proteogenomic analysis. The databases used were
(1) six-frame translated genome database, (2) three-frame translated
RefSeq mRNA sequences from NCBI, (3) three-frame translated pseudogene
database with sequences derived from sequences from NCBI and Gerstein&#x02019;s
pseudogenes, (4) three-frame translated non coding RNAs from NONCODE,
and (5) N-terminal UTR database of RefSeq mRNA sequences from NCBI.
A decoy database was created for each database by reversing the sequences
from a target database. Peptide identification was carried out using
X!Tandem. The following parameters were common to all searches: (1)
precursor mass error set at 10 ppm, (2) fragment mass error set at
0.05 Da, (3) carbamidomethylation of cysteine defined as a fixed modification,
(4) oxidation of methionine defined as a variable modification, and
(5) only tryptic peptides with up to two missed cleavages were considered.
The sequences of common contaminants including trypsin used as protease
were appended to the database. Unmatched MS/MS spectra peaklist files
were extracted from the protein database search result and searched
against these databases using the X!Tandem search engine installed
locally.</p><p>All the databases were created in-house using python
scripts. For the six-frame translated genome database, the human reference
genome assembly hg19 was downloaded from NCBI and translated in six
reading frames, and peptide sequences greater than six amino acids
were retained in the database. The mRNA sequences were downloaded
from NCBI RefSeq (RefSeq version 56 containing 33&#x02009;580 sequences)
and translated in three reading frames. Custom pseudogene database
from NCBI (11&#x02009;160 sequences) and Gerstein&#x02019;s pseudogene
database (16&#x02009;881 sequences from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pseudogene.org/">http://pseudogene.org/</uri>, version 68) as well as noncoding RNA sequences from NONCODE (91&#x02009;687
sequences, version 3) were translated in three reading frames.</p><p>Peptide sequences identified from each of the alternate database
searches were filtered, and only those passing 1% FDR score threshold
at the peptide level were considered. Unique lists of genome search
specific peptides (GSSPs), pseudogene specific peptides, and transcriptome
search specific peptides were generated by comparing the peptides
with the protein database. Peptides mapping to multiple regions in
the genome and with isoleucine/leucine ambiguity were not considered
for further analysis. The final list of the peptides was then manually
validated to verify the confidence of spectral assignment.</p></sec><sec id="sec2.5"><title>Gene Ontology
Analysis</title><p>Molecular functions and primary
localization information for all the proteins were obtained from Human
Protein Reference Database, HPRD (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.hprd.org">http://www.hprd.org</uri>),
containing manually curated protein annotations along with protein&#x02013;protein
interactions related to human proteins.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p></sec><sec id="sec2.6"><title>Quantitation Based on Spectral Counts</title><p>Normalized spectral
counts were calculated by summing spectral counts from all the peptides
mapping to a given gene per experiment (i.e., SDS-PAGE or bRPLC).
Total acquired tandem MS were then used to normalize between experiments,
and the resulting spectral counts per gene were averaged across multiple
experiments (e.g., bRPLC and SDS-PAGE fractionation) per sample (e.g.,
esophagus). Final numbers per gene were used for plotting the heat
map.</p></sec></sec><sec id="sec3"><title>Results and Discussion</title><sec id="sec3.1"><title>Proteomic Evidence for Genes on Chromosome
22</title><p>As part
of our deep proteomic profiling of 30 different histologically normal
human tissues and cell types using high-resolution mass spectrometry,
we specifically looked for proteins that are encoded by genes on chromosome
22. Of the 442 RefSeq gene entries, our data provides translation
evidence for protein products of 367 genes. Twenty proteins have &#x0003e;90%
sequence coverage and 52% of the proteins have sequence coverage &#x0003e;50%
(Figure <xref rid="fig1" ref-type="fig">1</xref>a). The distribution of identified
proteins based on their subcellular localization and molecular function
reveals proteins to be predominantly localized in the cytoplasm followed
by the nucleus and the plasma membrane (Figure <xref rid="fig1" ref-type="fig">1</xref>b). In addition to providing translation evidence for many of the
chromosome 22-encoded proteins, we also confirmed the start sites
of 120 proteins.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(a)
Sequence coverage of proteins encoded by chromosome 22. (b)
Distribution of identified chromosome-22-encoded proteins based on
subcellular localization. (c) Tissue-wise distribution of protein coding
genes encoded by chromosome 22. Distribution of proteins identified
from 30 histologically normal tissues and cell lines based on their
spectral abundance. The color schema is based on the spectral counts:
red blocks represent proteins with relatively higher expression, orange
depicts moderate expression, and yellow represents relatively low
expression. Proteins not detected in a given tissue are represented
in gray.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0001" id="GRAPHIC-d2587e626-autogenerated" position="float"/></fig><p>Figure <xref rid="fig1" ref-type="fig">1</xref>c depicts the relative expression
of chromosome 22-encoded proteins identified in this study based on
normalized spectral counts. Several proteins identified in our study
show tissue restricted expression. For example, proteins encoded by <italic>GNAZ</italic>, <italic>PDXP</italic>, <italic>PI4KA</italic>, <italic>SBF1</italic>, <italic>SYNGR1</italic>, and <italic>PRODH</italic> showed higher expression in adult frontal cortex compared to other
tissues, whereas those encoded by <italic>PARVG</italic>, <italic>EP300</italic>, <italic>THOC5</italic>, <italic>PARVB</italic>, and <italic>ADRBK2</italic> showed consistently high expression in the hematopoietic
cells compared to fetal and adult tissues. Parvins are actin-binding
proteins that form multiprotein complexes with integrin-linked kinases
that link integrins to the actin cytoskeleton. &#x003b3;-Parvin has
been reported to be expressed specifically in hematopoietic cells
of both myeloid and lymphoid origin and is in agreement with our findings.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> &#x003b2;-Parvin, another member of the parvin
family, shows high expression in platelets compared to all other tissues.
Interestingly, we identified proteins encoded by <italic>ACR</italic>, <italic>HORMAD2</italic>, <italic>TSSK2</italic>, and <italic>TMEM191B</italic>, among others, that showed relatively higher expression in adult
ovary and testis compared to other tissues sampled in our study.</p><p>When we compared our data with neXtProt entries, we found 317 of
356 proteins categorized as PE1 entries present in our data set. We
also compared our data with 337 genes from PeptideAtlas and 339 genes
from GPMDB.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> We found 63 genes unique to
our data set as compared to PeptideAtlas and 56 genes as compared
to GPMDB. This was made possible by the deep proteome coverage obtained
by combining diverse human samples, different fractionation strategies,
and high-resolution mass spectrometers.</p></sec><sec id="sec3.2"><title>&#x0201c;Missing&#x0201d;
Proteins Identified in Chromosome 22</title><p>To enable identification
of &#x0201c;missing proteins&#x0201d;, we
compared our list of proteins encoded by chromosome 22 with the list
of &#x0201c;missing proteins&#x0201d; derived from proteins that do
not have any proteomic evidence in neXtProt, PeptideAtlas, or GPMDB.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Based on the current metrics<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>, 108 proteins are reported to be missing or lacking proteomic
evidence from chromosome 22. Of these, 21 are currently categorized
as PE5 entries. Comparing our list of identified proteins with neXtProt
database resulted in the identification of 47 missing proteins, which
include 5 of 21 proteins designated as uncertain/dubious (<xref rid="notes-2" ref-type="notes">Supplementary Table S1</xref>).</p><p>On the basis of
our analysis, we observed several proteins that showed tissue-restricted
expression, whereas only a few showed ubiquitous expression (Figure <xref rid="fig2" ref-type="fig">2</xref>). Proteins encoded by <italic>ATP5L2</italic>,<italic> DDTL</italic>,<italic> TSPO</italic>, and <italic>POTEH</italic> show ubiquitous expression across all tissues with certain tissues
showing higher expression than in others. For example, translocator
protein (TSPO), a mitochondrial membrane protein involved in various
physiological functions, including immunologic responses,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> showed high expression in monocytes followed
by other hematopoietic cells. In the case of tissue-restricted expression,
CECR6, one of the dosage-sensitive genes responsible for cat eye syndrome
(CES)<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> was identified from our study specifically
in the brain with higher expression in adult frontal cortex compared
to fetal brain. Three RIMBP3 genes&#x02014;<italic>RIMBP3</italic>,<italic> RIMBP3B</italic>, and <italic>RIMBP3C</italic>&#x02014;are located
on chromosome 22, and each of these is a single exon gene sharing
99% identity at nucleotide level.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> All
RIMBP3 genes contain a central SH3 domain, followed by two FN3 domains
and two <italic>C</italic>-terminal SH3 domains. RNASeq data from
Illumina BodyMap shows transcript expression in several tissues, with
the highest expression in testis. We identified gene-specific peptides
only for RIMBP3, with relatively high expression in testis, consistent
with the transcriptome data. Another protein, RIBC2 (RIB43A domain
with coiled-coils 2) also known as <italic>C22orf11</italic>, is expressed
only in fetal tissues and has the highest expression in fetal heart. <italic>RIBC2</italic> is located on the q13.31 locus and consists of two-coiled
coil domains. The biological role of this protein has not been determined
but it seems to play a role in early developmental stages. In addition,
proteins encoded by solute carrier family members located on this
chromosome, such as <italic>SLC5A4</italic> (adult kidney), <italic>SLC35E4</italic>,<italic> SLC2A11</italic> (high expression in fetal
brain), <italic>SLC16A8</italic> (adult retina), and <italic>SLC7A4</italic> (adult testis), have been identified with tissue-restricted expression
pattern. Thus, sampling specific tissue/cell types has enabled us
to identify majority of the missing proteins that had been missed
earlier.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Tissue-wise expression of &#x0201c;missing proteins&#x0201d; identified
by proteomic study. Distribution of &#x0201c;missing&#x0201d; proteins
identified in this study from 30 histologically normal tissues and
cell lines based on their spectral abundance. The color schema is
based on the spectral counts: red blocks represent proteins with relatively
higher expression, orange depicts moderate expression, and yellow
represents relatively low expression. Proteins not detected in a given
tissue are represented in gray.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0002" id="gr4" position="float"/></fig></sec><sec id="sec3.3"><title>Gene Families on Chromosome 22</title><p>Several gene families
have been reported to be clustered on chromosome 22. Gene families
on the same chromosome are presumed to have arisen by tandem gene
duplication. Figure <xref rid="fig3" ref-type="fig">3</xref>a depicts some of the
gene families on this chromosome. The immunoglobulin &#x003bb; locus,
which encodes the light chain of antibodies, is one such gene family
clustered on chromosome 22.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> In addition
to the lambda locus, there are other immunoglobulin-related genes
on this chromosome such as immunoglobulin &#x003bb;-like (<italic>IGLL</italic>) family and immunoglobulin k variable-region pseudogenes. Apart
from the immunoglobulin genes, gene families that encode glutathione <italic>S</italic>-transferases,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Ret-finger-like
proteins,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup><italic>APOL</italic> family,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and &#x003b2;-crystallins<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> are present on this chromosome. The &#x003b3;-glutamyl transferase
genes represent a family that is likely to have been duplicated in
tandem along with other gene families such as the BCR-like genes that
span the 22q11 region. Together these genes form the LCR22 (low-copy
repeat 22) repeats. The APOBEC gene family, which is involved in deaminating
cytosine to uracil, has 7 of 10 members clustered on chromosome 22.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> These genes are involved in RNA/DNA editing
and exhibit diverse physiological functions.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup><italic>APOBEC1</italic>, the first member to be discovered, is
involved in deaminating apolipoprotein B RNA, thereby creating a premature
stop codon and producing a shorter protein.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Tissue-wise distribution of the APOBEC proteins reveals a relatively
higher abundance in hematopoietic cells compared to adult and fetal
tissues (Figure <xref rid="fig3" ref-type="fig">3</xref>b). Interestingly, our analysis
shows APOBEC3H to be restricted in its expression to adult liver tissue.
This gene is known to possess antiretroviral activity and inhibits
retrovirus replication and retrotransposon mobility by deamination.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup></p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>(a) Selected examples of gene families on chromosome 22. The gene
families are shown in boxes with information pertaining to band annotation.
Within parentheses, the details of the gene family are provided in
the following order: number of genes of a family adjacent to each
other/total number of members on the chromosome/total family members
in the genome. (b) Panel shows tissue-wise distribution of APOBEC gene family on chromosome 22. 7 of 10 APOBEC gene family members are clustered on chromosome 22.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0003" id="GRAPHIC-d2587e819-autogenerated" position="float"/></fig></sec><sec id="sec3.4"><title>Cancer-Associated Genes
on Chromosome 22</title><p>Chromosome
22 is also known to have strong association with cancers and is extensively
rearranged in several tumors, including chronic myeloid leukemia,
astrocytic tumors,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> and neurofibromatosis
type 2a.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Table <xref rid="tbl1" ref-type="other">1</xref> lists several known cancer-associated genes located on this chromosome,
including some of the prominent genes such as <italic>BCR</italic> (Philadelphia chromosome &#x02013; translocation), <italic>CRKL</italic> (chronic myeloid leukemia), <italic>PDGFB</italic> (glioma), and
genes associated with some rare tumors, including <italic>SMARCB1</italic> (rhabdoid tumor), <italic>MN1</italic> (meningioma), <italic>EWSR1</italic> (Ewing&#x02019;s sarcoma), and <italic>NF2</italic> (schwannoma tumors).
A complete list of cancer-associated genes on chromosome 22 has been
generated using the method described by Liu et al.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> On the basis of the information related to oncogenes integrated
from several websites (Sanger, Waldman, and GeneCards, see legends
Table <xref rid="tbl1" ref-type="other">1</xref>), we have identified 24 genes on chromosome
22. Nineteen of the 24 cancer-associated genes are present in regions
which are transcriptionally active with gene density above the average
on chromosome 22 (i.e., 51.6 genes/Mb). Only five genes occur in a
region with &#x0003c;45 genes per Mb.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>List of Cancer-Associated Genes on
Chromosome 22</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="center"/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th colspan="7" align="center">cancer gene list
for chromosome 22<hr/></th></tr><tr><th style="border:none;" align="center">position</th><th style="border:none;" align="center">oncogene</th><th style="border:none;" align="center">Sanger(S)/Waldman(W)/cancer&#x000a0;index(C)<xref rid="t1fn1" ref-type="table-fn">a</xref></th><th style="border:none;" align="center">top Novoseek cancer association<xref rid="t1fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center">GeneCards Novoseek-logP<xref rid="t1fn3" ref-type="table-fn">c</xref></th><th style="border:none;" align="center" char=".">adjacent cancer-related genes score<xref rid="t1fn4" ref-type="table-fn">d</xref></th><th style="border:none;" align="center" char=".">gene density<xref rid="t1fn5" ref-type="table-fn">e</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>22q11.21</bold></td><td style="border:none;" align="left"><bold>BID</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">tumors</td><td style="border:none;" align="center">52.3</td><td style="border:none;" align="char" char=".">4</td><td style="border:none;" align="char" char=".">90</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>CLTCL1</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">n/a</td><td style="border:none;" align="center">n/a</td><td style="border:none;" align="char" char=".">12</td><td style="border:none;" align="char" char=".">100</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>COMT</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">breast cancer</td><td style="border:none;" align="center">49.4</td><td style="border:none;" align="char" char=".">17</td><td style="border:none;" align="char" char=".">100</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>CRKL</bold></td><td style="border:none;" align="left">W,C</td><td style="border:none;" align="left">chronic myeloid leukemia</td><td style="border:none;" align="center">77.7</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">98</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>SEPT5</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">leukemia</td><td style="border:none;" align="center">0</td><td style="border:none;" align="char" char=".">21</td><td style="border:none;" align="char" char=".">100</td></tr><tr><td style="border:none;" align="left"><bold>22qll.23</bold></td><td style="border:none;" align="left"><bold>BCR</bold><xref rid="t1fn6" ref-type="table-fn">f</xref></td><td style="border:none;" align="left">S,W,C</td><td style="border:none;" align="left"><italic>chronic myeloid leukemia</italic></td><td style="border:none;" align="center">91.4</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">130</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>GSTT1</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">bladder cancer</td><td style="border:none;" align="center">56.9</td><td style="border:none;" align="char" char=".">16</td><td style="border:none;" align="char" char=".">251</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>MIF</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">tumors</td><td style="border:none;" align="center">44.9</td><td style="border:none;" align="char" char=".">16</td><td style="border:none;" align="char" char=".">251</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>MMP11</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">breast carcinoma</td><td style="border:none;" align="center">64.3</td><td style="border:none;" align="char" char=".">21</td><td style="border:none;" align="char" char=".">251</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>SMARCB1</bold></td><td style="border:none;" align="left">S,C</td><td style="border:none;" align="left"><italic>rhabdoid tumor</italic></td><td style="border:none;" align="center">97</td><td style="border:none;" align="char" char=".">16</td><td style="border:none;" align="char" char=".">251</td></tr><tr><td style="border:none;" align="left"><bold>22ql2.1</bold></td><td style="border:none;" align="left"><bold>CHEK2</bold></td><td style="border:none;" align="left">S,C</td><td style="border:none;" align="left">breast cancer</td><td style="border:none;" align="center">54.6</td><td style="border:none;" align="char" char=".">13</td><td style="border:none;" align="char" char=".">52</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>MN1</bold></td><td style="border:none;" align="left">S,C</td><td style="border:none;" align="left"><italic>meningioma</italic></td><td style="border:none;" align="center">68.3</td><td style="border:none;" align="char" char=".">12</td><td style="border:none;" align="char" char="."><bold>21</bold></td></tr><tr><td style="border:none;" align="left"><bold>22ql2.2</bold></td><td style="border:none;" align="left"><bold>EWSR1</bold></td><td style="border:none;" align="left">S,C</td><td style="border:none;" align="left"><italic>Ewing&#x02019;s sarcoma</italic></td><td style="border:none;" align="center">96.3</td><td style="border:none;" align="char" char=".">13</td><td style="border:none;" align="char" char=".">52</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>LIF</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">leukemia</td><td style="border:none;" align="center">94.9</td><td style="border:none;" align="char" char=".">8</td><td style="border:none;" align="char" char=".">70</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>NF2</bold><xref rid="t1fn6" ref-type="table-fn">f</xref></td><td style="border:none;" align="left">S,W,C</td><td style="border:none;" align="left"><italic>schwannoma tumors</italic></td><td style="border:none;" align="center">89.9</td><td style="border:none;" align="char" char=".">13</td><td style="border:none;" align="char" char=".">52</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>PATZ1</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">colon carcinoma</td><td style="border:none;" align="center">35.6</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x000a0;</td></tr><tr><td style="border:none;" align="left"><bold>22ql2.3</bold></td><td style="border:none;" align="left"><bold>MYH9</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">leukemia</td><td style="border:none;" align="center">17.9</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char="."><bold>44</bold></td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>TIMP3</bold></td><td style="border:none;" align="left">W</td><td style="border:none;" align="left">tumors</td><td style="border:none;" align="center">57.7</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char="."><bold>23</bold></td></tr><tr><td style="border:none;" align="left"><bold>22ql3.1</bold></td><td style="border:none;" align="left"><bold>MKL1</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">acute megakaryoblastic leukemia</td><td style="border:none;" align="center">78.3</td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char="."><bold>36</bold></td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>PDGFB</bold><xref rid="t1fn6" ref-type="table-fn">f</xref></td><td style="border:none;" align="left">S,W,C</td><td style="border:none;" align="left"><bold>glioma*</bold></td><td style="border:none;" align="center">50.4</td><td style="border:none;" align="char" char=".">10</td><td style="border:none;" align="char" char=".">84</td></tr><tr><td style="border:none;" align="left"><bold>22ql3.2</bold></td><td style="border:none;" align="left"><bold>BIK</bold></td><td style="border:none;" align="left">C</td><td style="border:none;" align="left">breast cancer</td><td style="border:none;" align="center">14.3</td><td style="border:none;" align="char" char=".">3</td><td style="border:none;" align="char" char="."><bold>40</bold></td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>CYP2D6</bold></td><td style="border:none;" align="left">W,C</td><td style="border:none;" align="left">breast cancer</td><td style="border:none;" align="center">26.4</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">110</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left"><bold>EP300</bold></td><td style="border:none;" align="left">S</td><td style="border:none;" align="left">leukemia</td><td style="border:none;" align="center">60.5</td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">68</td></tr><tr><td style="border:none;" align="left"><bold>22ql3.33</bold></td><td style="border:none;" align="left"><bold>TYMP</bold></td><td style="border:none;" align="left">W</td><td style="border:none;" align="left">tumors</td><td style="border:none;" align="center">71.4</td><td style="border:none;" align="char" char=".">3</td><td style="border:none;" align="char" char=".">72</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Websites that list oncogene information
are <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.sanger.ac.uk/genetics/CGP/Census/">http://www.sanger.ac.uk/genetics/CGP/Census/</uri>, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://waldman.ucsf.edu/GENES/completechroms.html">http://waldman.ucsf.edu/GENES/completechroms.html</uri>, and <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cancerindex.org/geneweb/genes_d.htm">http://www.cancerindex.org/geneweb/genes_d.htm</uri>.</p></fn><fn id="t1fn2"><label>b</label><p>Top cancer association from GeneCards
Novoseek disease relationship table, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.genecards.org/">http://www.genecards.org/</uri>.</p></fn><fn id="t1fn3"><label>c</label><p>-logP of top cancer association
(b) from GeneCards Novoseek disease relationship table, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.genecards.org/">http://www.genecards.org/</uri>.</p></fn><fn id="t1fn4"><label>d</label><p>Information derived from
neXtProt
and GeneCards. As a way to assess degree of cancer association, we
have calculated a score as follows: the adjacent 10 genes on either
side of the oncogene (from neXtProt) are scored as oncogene designation
+5 points, direct literature association with cancer +3 points, present
in cancer data sets +1 point.</p></fn><fn id="t1fn5"><label>e</label><p>The gene density was derived from
GeneCards: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://genecards.weizmann.ac.il/geneloc-bin/gene_densities.pl">http://genecards.weizmann.ac.il/geneloc-bin/gene_densities.pl</uri>. All values represent the regions with a gene density above the
average on chromosome 22 (i.e., 51.6 genes/Mb), except for numbers
indicated in <bold>bold</bold>.</p></fn><fn id="t1fn6"><label>f</label><p>Recognized as driver oncogene.</p></fn><fn id="t1fn7"><p>Italic
text indicates known <bold>gene mutation</bold> associated with cancer.</p></fn><fn id="t1fn8"><p><bold>Bold text and *</bold> indicates cancer
gene
target with therapy from My Cancer Genome, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.mycancergenome.org/">http://www.mycancergenome.org/</uri>.</p></fn></table-wrap-foot></table-wrap><p><italic>NF2,</italic> a gene responsible for neurofibromatosis
type 2, encodes a cytoskeletal associating protein, Merlin. Merlin
is similar to the ERM (Ezrin&#x02013;Radixin&#x02013;Moesin) family
of proteins and has been implicated in the regulation of a number
of signaling pathways, including Rac1,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Ras/MAPK,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> mTOR,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> and Hippo pathways.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup><italic>NF2</italic> has been reported to be a negative regulator of Rac
signaling.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Several studies have reported <italic>NF2</italic> as a tumor suppressor protein.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> Deletion and mutations in the <italic>NF2</italic> gene have been
shown to cause autosomal dominant predisposition to tumors in the
nervous system and skin.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> In addition,
several mutations and breakpoints are reported in the <italic>NF2</italic> gene locus located in the 22q12 region of chromosome 22. This gene
locus lies in one of the transcriptionally active regions on the chromosome
and consists of genes such as <italic>LIF</italic> and <italic>NEFH</italic> in addition to several cancer-associated genes, including <italic>EWSR1</italic>, which contains the Ewing&#x02019;s sarcoma translocation
breakpoint, and other known tumor suppressor genes, <italic>GAS2L1</italic> and <italic>RASL10A</italic>.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Figure <xref rid="fig4" ref-type="fig">4</xref> illustrates some of these important genes clustered
around <italic>NF2</italic> as well as the diversity of protein isoforms
of these genes in terms of the number of alternative splice variants
(ASVs, red circle) and single nucleotide variants (SNVs, purple circle)
resulting from the transcription of missense SNPs. Genes with a significant
number of variants in the region include <italic>NF2</italic> with
11 ASVs and 90 SNVs, <italic>ASCC2</italic> (10, 26), <italic>MTMR3</italic> (6, 36), and <italic>TBC1D10A</italic> (6, 17). <italic>RFPL1</italic>, <italic>RASL10A</italic>,<italic> UQCR10</italic>,<italic> ZMAT5</italic>, and <italic>HORMAD2</italic> are currently categorized as &#x0201c;missing
proteins&#x0201d; with no evidence at the proteome level. In our proteomics
data, we observed HORMAD2 to be expressed ubiquitously with relatively
high expression in adult testis and RFPL1 with restricted expression
in fetal heart. This warrants further studies to be performed to functionally
characterize these proteins as they may have an impact on the phenotype
and could likely contribute to disease progression in <italic>NF2</italic> deleted/mutated tumors.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Genes around <italic>NF2</italic>. Ten genes
adjacent to <italic>NF2</italic> have been considered for the analysis.
Genes in filled
boxes (blue shade) have evidence of PTMs, whereas genes in unfilled
boxes have no known PTMs. Red circles within the boxes indicate number
of alternative splice variants in Ensembl/neXtProt. Purple circles
denote number of proteins in neXtProt.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0004" id="gr7" position="float"/></fig></sec><sec id="sec3.5"><title>Proteogenomic Analysis</title><p>Evidence for the protein-coding
potential of the genome has been largely dependent on gene prediction
algorithms and sometimes on the presence of corresponding transcripts
or orthologous genes. Currently, about 50% of human transcripts are
classified as noncoding. In recent years, mass spectrometry-derived
data has been employed to refine/redefine the genome annotation of
various organisms.<sup><xref ref-type="bibr" rid="ref45">45</xref>&#x02212;<xref ref-type="bibr" rid="ref48">48</xref></sup> Employing a proteogenomics strategy established previously by our
group, we discovered several potential novel coding regions on chromosome
22. From our large scale proteome analysis, following the protein
database search, unmatched spectra were extracted and searched using
reference genome translated into six reading frames, RefSeq transcript
sequences translated in three reading frames, and custom databases
of annotated pseudogenes and conceptually translated protein N-termini
databases. Our analysis resulted in the identification of 10 novel
events on chromosome 22 including identification of upstream ORFs,
evidence for translation of noncoding RNA correction/refinement of
gene structure. The summary of the analysis is provided in Table <xref rid="tbl2" ref-type="other">2</xref>. The details of all the proteogenomic annotation
on chromosome 22 is provided in <xref rid="notes-2" ref-type="notes">Supplementary
Table S2</xref>.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Summary of Novel Findings Identified
through Proteogenomics</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">category</th><th style="border:none;" align="center" char=".">no. of cases</th></tr></thead><tbody><tr><td style="border:none;" align="left">novel&#x000a0;coding&#x000a0;region&#x000a0;(upstream&#x000a0;ORF)</td><td style="border:none;" align="char" char=".">2</td></tr><tr><td style="border:none;" align="left">novel&#x000a0;coding&#x000a0;exons</td><td style="border:none;" align="char" char=".">2</td></tr><tr><td style="border:none;" align="left">translation&#x000a0;evidence&#x000a0;for&#x000a0;noncoding&#x000a0;RNA</td><td style="border:none;" align="char" char=".">1</td></tr><tr><td style="border:none;" align="left">translation&#x000a0;evidence&#x000a0;for&#x000a0;pseudogene</td><td style="border:none;" align="char" char=".">1</td></tr><tr><td style="border:none;" align="left">novel&#x000a0;N-termini</td><td style="border:none;" align="char" char=".">3</td></tr></tbody></table></table-wrap><p>It is estimated that 41&#x02013;49% of all known human RefSeq transcripts
with annotated 5&#x02032; UTR contain at least one upstream ORF.<sup><xref ref-type="bibr" rid="ref49">49</xref>&#x02212;<xref ref-type="bibr" rid="ref51">51</xref></sup> Studies have shown that uAUG codons and associated upstream ORFs
in the 5&#x02032;-UTR region play an important role in translational
control of mRNAs. From our analysis, we identified two cases of uORFs.
MIEF1 is a mitochondrial membrane
protein that regulates mitochondrial membrane dynamics.<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> Overexpression of <italic>MIEF1</italic> was shown to cause extensive
mitochondrial fission, recruitment of DRP1 to mitochondria membrane,
and formation of long mitochondrial tubules. Conversely, <italic>MIEF1</italic> knockdown resulted in mitochondrial fission and fragmentation. A
targeted database search against three-frame translated transcript
database resulted in the identification of a peptide &#x0201c;YTDRDFYFASIR&#x0201d;
in the 5&#x02032; UTR region of <italic>MIEF1</italic> (Figure <xref rid="fig5" ref-type="fig">5</xref>a). The translated ORF is 70 amino acids in length
and is conserved in rabbit and giant panda. Further studies have to
be carried out to delineate the role of the uORF in <italic>MIEF1</italic> function.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>(a) Identification
of novel upstream ORF in the 5&#x02032; untranslated
region of mitochondrial elongation factor 1 (<italic>MIEF1</italic>). The figure represents peptide sequence &#x0201c;YTDRDFYFASIR&#x0201d;
mapping to 5&#x02032;UTR of <italic>MIEF1</italic> (SMCR7L). In silico
translation of the 5&#x02032;UTR region revealed the presence of a
novel ORF of 70 amino acids. Sequence alignment shows conservation
of the novel ORF with other mammals. The alignment of the peptide
sequence identified in our study has been highlighted in the panel
depicting sequence alignment with rabbit and panda. (b) N-terminal
extension of tyrosylprotein sulfotransferase (<italic>TPST2</italic>). The figure represents peptide sequences &#x0201c;ALPADSLGTQAQGELEPR&#x0201d;
and &#x0201c;CEPGGLPANLSLKPQK&#x0201d; mapping to 5&#x02032;UTR of <italic>TPST2</italic> just upstream of the currently annotated translation
start site. The peptide sequences are translated in the same frame
as the existing protein. Sequence alignment with other primate species
reveals existence of an alternate translation start site 210 bp upstream
of the currently annotated start site. (c) Evidence of translation
on noncoding RNA (<italic>FAM230B</italic>) The figure represents
peptide sequence &#x0201c;EDAAQGIANEAADK&#x0201d; mapping to noncoding
RNA FAM230B. GENSCAN, a gene prediction algorithm, predicts an ORF
in this region. (d) Identification of novel coding exon in the intron
of smoothelin (<italic>SMTN</italic>). We identified &#x0201c;VAVTQAAEVAVATVEPVAR&#x0201d;
mapping to the intronic region of <italic>SMTN</italic> between exon
9 and 10. Our finding is also supported by several ESTs (subset listed
in the figure) as well as GENSCAN prediction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr-2013-01169d_0005" id="GRAPHIC-d2587e1606-autogenerated" position="float"/></fig><p>Based on our proteogenomics
analysis, we identified two cases of
N-terminal extension of proteins including extension of tyrosylprotein
sulfotransferase (<italic>TPST2</italic>) (Figure <xref rid="fig5" ref-type="fig">5</xref>b) and Ran GTPase activating protein 1 (<italic>RANGAP1</italic>) both with orthologous evidence in primates. We also provide evidence
for noncoding RNA, <italic>FAM230B</italic> (Figure <xref rid="fig5" ref-type="fig">5</xref>c) and translation of intronic region of smoothelin (<italic>SMTN</italic>), which encodes a structural protein that is found
exclusively in contractile smooth muscle cells. It is known to associate
with stress fibers and constitutes part of the cytoskeleton. This
gene is localized to chromosome 22q12.3 (Figure <xref rid="fig5" ref-type="fig">5</xref>d). The representative MS/MS spectra of the peptides identified are
provided in <xref rid="notes-2" ref-type="notes">Supplementary Figure 1</xref>.</p></sec></sec><sec sec-type="conclusions" id="sec4"><title>Conclusions</title><p>High-resolution mass spectrometry has enabled us to carry out deep
proteome profiling resulting in the high confidence identification
of the proteome. Additionally, we have also been able to identify
47 proteins that were previously reported to be missing. Future studies
have to be aimed at identifying proteins that are still missed using
the targeted approach and sampling of tissues and cells. In addition,
generation of MRM assays for proteins encoded by chromosome 22 becomes
imperative as the disease-associated role of genes on this chromosome
is evident. Proteogenomics has enabled redefining the genome annotation
in several organisms, and we have demonstrated its ability to identify
several novel events that have previously not been reported. The future
efforts of C-HPP should enable characterization of these novel events
in addition to focusing on the proteome that currently lacks proteomic
evidence. Furthermore, a concerted effort is required to map the different
post-translational modifications and subproteomes and to identify
protein interaction networks of genes encoded by chromosome 22.</p><sec id="sec4.1"><title>Data Availability</title><p>The mass spectrometry proteomics
data have been deposited to the ProteomeXchange consortium (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://proteomecentral.proteomexchange.org">http://proteomecentral.proteomexchange.org</uri>) via the PRIDE partner repository<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> with
the data set identifier PXD000561.</p></sec></sec></body><back><notes id="notes-2" notes-type="si"><title>Supporting Information Available</title><p>Representative MS/MS spectra
of peptides identified by proteogenomics analysis, a list of proteins
designated &#x0201c;missing proteins&#x0201d; identified by our study,
and a summary of novel protein features on chromosome 22 identified
through proteogenomic analysis. This material is available free of
charge via the Internet at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr401169d_si_001.pdf"><caption><p>pr401169d_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr401169d_si_002.xlsx"><caption><p>pr401169d_si_002.xlsx</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile3"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pr401169d_si_003.xlsx"><caption><p>pr401169d_si_003.xlsx</p></caption></media></supplementary-material></sec><notes id="notes-1" notes-type="conflict-of-interest"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We thank Drs. Lydie Lane and Amos Bairoch for providing us
with the list of missing genes. This work was supported by an NIH
roadmap grant for Technology Centers of Networks and Pathways (U54GM103520),
NCI&#x02019;s Clinical Proteomic Tumor Analysis Consortium initiative
(U24CA160036), a contract (HHSN268201000032C) from the National Heart,
Lung and Blood Institute and the Sol Goldman Pancreatic Cancer Research
Center. T.S.K.P is supported by DBT Program Support on Neuroproteomics
(BT/01/COE/08/05) to IOB. H.G. is a Wellcome Trust-DBT India Alliance
Early Career Fellow. S.M.P. is a recipient of Senior Research Fellowship
from Council of Scientific and Industrial Research (CSIR), Government
of India. S.S.M. is recipient of a Senior Research Fellowship from
the University Grants Commission (UGC), India.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Paik</surname><given-names>Y. K.</given-names></name>; <name><surname>Jeong</surname><given-names>S. K.</given-names></name>; <name><surname>Omenn</surname><given-names>G. S.</given-names></name>; <name><surname>Uhlen</surname><given-names>M.</given-names></name>; <name><surname>Hanash</surname><given-names>S.</given-names></name>; <name><surname>Cho</surname><given-names>S. Y.</given-names></name>; <name><surname>Lee</surname><given-names>H. J.</given-names></name>; <name><surname>Na</surname><given-names>K.</given-names></name>; <name><surname>Choi</surname><given-names>E. Y.</given-names></name>; <name><surname>Yan</surname><given-names>F.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Snyder</surname><given-names>M.</given-names></name>; <name><surname>Cheng</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>; <name><surname>Marko-Varga</surname><given-names>G.</given-names></name>; <name><surname>Deutsch</surname><given-names>E. W.</given-names></name>; <name><surname>Kim</surname><given-names>H.</given-names></name>; <name><surname>Kwon</surname><given-names>J. Y.</given-names></name>; <name><surname>Aebersold</surname><given-names>R.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Taylor</surname><given-names>A. D.</given-names></name>; <name><surname>Kim</surname><given-names>K. Y.</given-names></name>; <name><surname>Lee</surname><given-names>E. Y.</given-names></name>; <name><surname>Hochstrasser</surname><given-names>D.</given-names></name>; <name><surname>Legrain</surname><given-names>P.</given-names></name>; <name><surname>Hancock</surname><given-names>W. S.</given-names></name>
<article-title>The Chromosome-Centric Human Proteome
Project for cataloging proteins encoded in the genome</article-title>. <source>Nat. Biotechnol.</source>
<year>2012</year>, <volume>30</volume><issue>3</issue><fpage>221</fpage>&#x02013;<lpage>223</lpage>.<pub-id pub-id-type="pmid">22398612</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Lane</surname><given-names>L.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Beavis</surname><given-names>R. C.</given-names></name>; <name><surname>Deutsch</surname><given-names>E. W.</given-names></name>; <name><surname>Gaudet</surname><given-names>P.</given-names></name>; <name><surname>Lundberg</surname><given-names>E.</given-names></name>; <name><surname>Omenn</surname><given-names>G. S.</given-names></name>
<article-title>Metrics for the Human Proteome Project
2013&#x02013;2014 and strategies for finding missing proteins</article-title>. <source>J. Proteome Res.</source>
<year>2014</year>, <volume>13</volume><issue>1</issue><fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">24364385</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Lee</surname><given-names>H. J.</given-names></name>; <name><surname>Jeong</surname><given-names>S. K.</given-names></name>; <name><surname>Na</surname><given-names>K.</given-names></name>; <name><surname>Lee</surname><given-names>M. J.</given-names></name>; <name><surname>Lee</surname><given-names>S. H.</given-names></name>; <name><surname>Lim</surname><given-names>J. S.</given-names></name>; <name><surname>Cha</surname><given-names>H. J.</given-names></name>; <name><surname>Cho</surname><given-names>J. Y.</given-names></name>; <name><surname>Kwon</surname><given-names>J. Y.</given-names></name>; <name><surname>Kim</surname><given-names>H.</given-names></name>; <name><surname>Song</surname><given-names>S. Y.</given-names></name>; <name><surname>Yoo</surname><given-names>J. S.</given-names></name>; <name><surname>Park</surname><given-names>Y. M.</given-names></name>; <name><surname>Hancock</surname><given-names>W. S.</given-names></name>; <name><surname>Paik</surname><given-names>Y. K.</given-names></name>
<article-title>Comprehensive genome-wide proteomic analysis of human
placental tissue for the Chromosome-Centric Human Proteome Project</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>12</volume><issue>6</issue><fpage>2458</fpage>&#x02013;<lpage>2466</lpage>.<pub-id pub-id-type="pmid">23362793</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Segura</surname><given-names>V.</given-names></name>; <name><surname>Medina-Aunon</surname><given-names>J. A.</given-names></name>; <name><surname>Mora</surname><given-names>M. I.</given-names></name>; <name><surname>Martinez-Bartolome</surname><given-names>S.</given-names></name>; <name><surname>Abian</surname><given-names>J.</given-names></name>; <name><surname>Aloria</surname><given-names>K.</given-names></name>; <name><surname>Antunez</surname><given-names>O.</given-names></name>; <name><surname>Arizmendi</surname><given-names>J. M.</given-names></name>; <name><surname>Azkargorta</surname><given-names>M.</given-names></name>; <name><surname>Barcelo-Batllori</surname><given-names>S.</given-names></name>; <name><surname>Beaskoetxea</surname><given-names>J.</given-names></name>; <name><surname>Bech-Serra</surname><given-names>J. J.</given-names></name>; <name><surname>Blanco</surname><given-names>F.</given-names></name>; <name><surname>Monteiro</surname><given-names>M. B.</given-names></name>; <name><surname>Caceres</surname><given-names>D.</given-names></name>; <name><surname>Canals</surname><given-names>F.</given-names></name>; <name><surname>Carrascal</surname><given-names>M.</given-names></name>; <name><surname>Casal</surname><given-names>J. I.</given-names></name>; <name><surname>Clemente</surname><given-names>F.</given-names></name>; <name><surname>Colome</surname><given-names>N.</given-names></name>; <name><surname>Dasilva</surname><given-names>N.</given-names></name>; <name><surname>Diaz</surname><given-names>P.</given-names></name>; <name><surname>Elortza</surname><given-names>F.</given-names></name>; <name><surname>Fernandez-Puente</surname><given-names>P.</given-names></name>; <name><surname>Fuentes</surname><given-names>M.</given-names></name>; <name><surname>Gallardo</surname><given-names>O.</given-names></name>; <name><surname>Gharbi</surname><given-names>S. I.</given-names></name>; <name><surname>Gil</surname><given-names>C.</given-names></name>; <name><surname>Gonzalez-Tejedo</surname><given-names>C.</given-names></name>; <name><surname>Hernaez</surname><given-names>M. L.</given-names></name>; <name><surname>Lombardia</surname><given-names>M.</given-names></name>; <name><surname>Lopez-Lucendo</surname><given-names>M.</given-names></name>; <name><surname>Marcilla</surname><given-names>M.</given-names></name>; <name><surname>Mato</surname><given-names>J. M.</given-names></name>; <name><surname>Mendes</surname><given-names>M.</given-names></name>; <name><surname>Oliveira</surname><given-names>E.</given-names></name>; <name><surname>Orera</surname><given-names>I.</given-names></name>; <name><surname>Pascual-Montano</surname><given-names>A.</given-names></name>; <name><surname>Prieto</surname><given-names>G.</given-names></name>; <name><surname>Ruiz-Romero</surname><given-names>C.</given-names></name>; <name><surname>Sanchez Del Pino</surname><given-names>M. M.</given-names></name>; <name><surname>Tabas-Madrid</surname><given-names>D.</given-names></name>; <name><surname>Valero</surname><given-names>M. L.</given-names></name>; <name><surname>Vialas</surname><given-names>V.</given-names></name>; <name><surname>Villanueva</surname><given-names>J.</given-names></name>; <name><surname>Albar</surname><given-names>J. P.</given-names></name>; <name><surname>Corrales</surname><given-names>F. J.</given-names></name>
<article-title>Surfing transcriptomic landscapes.
A step beyond the annotation of chromosome 16 proteome</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>13</volume><issue>1</issue><fpage>158</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">24138474</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Wen</surname><given-names>B.</given-names></name>; <name><surname>Yan</surname><given-names>G.</given-names></name>; <name><surname>Wei</surname><given-names>J.</given-names></name>; <name><surname>Xie</surname><given-names>L.</given-names></name>; <name><surname>Xu</surname><given-names>S.</given-names></name>; <name><surname>Jiang</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Lin</surname><given-names>L.</given-names></name>; <name><surname>Zi</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Zhou</surname><given-names>R.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name>; <name><surname>Ren</surname><given-names>Z.</given-names></name>; <name><surname>Qu</surname><given-names>N.</given-names></name>; <name><surname>Lou</surname><given-names>X.</given-names></name>; <name><surname>Sun</surname><given-names>H.</given-names></name>; <name><surname>Du</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>S.</given-names></name>; <name><surname>Tan</surname><given-names>F.</given-names></name>; <name><surname>Xian</surname><given-names>Y.</given-names></name>; <name><surname>Gao</surname><given-names>Z.</given-names></name>; <name><surname>He</surname><given-names>M.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>P.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Yin</surname><given-names>X.</given-names></name>; <name><surname>Shen</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Jiang</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Chang</surname><given-names>C.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Yao</surname><given-names>J.</given-names></name>; <name><surname>Lu</surname><given-names>H.</given-names></name>; <name><surname>Ying</surname><given-names>W.</given-names></name>; <name><surname>Zhong</surname><given-names>F.</given-names></name>; <name><surname>He</surname><given-names>Q. Y.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>
<article-title>Qualitative
and quantitative expression status of the human chromosome 20 genes
in cancer tissues and the representative cell lines</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>12</volume><issue>1</issue><fpage>151</fpage>&#x02013;<lpage>161</lpage>.<pub-id pub-id-type="pmid">23252959</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Fagerberg</surname><given-names>L.</given-names></name>; <name><surname>Oksvold</surname><given-names>P.</given-names></name>; <name><surname>Skogs</surname><given-names>M.</given-names></name>; <name><surname>Algenas</surname><given-names>C.</given-names></name>; <name><surname>Lundberg</surname><given-names>E.</given-names></name>; <name><surname>Ponten</surname><given-names>F.</given-names></name>; <name><surname>Sivertsson</surname><given-names>A.</given-names></name>; <name><surname>Odeberg</surname><given-names>J.</given-names></name>; <name><surname>Klevebring</surname><given-names>D.</given-names></name>; <name><surname>Kampf</surname><given-names>C.</given-names></name>; <name><surname>Asplund</surname><given-names>A.</given-names></name>; <name><surname>Sjostedt</surname><given-names>E.</given-names></name>; <name><surname>Al-Khalili
Szigyarto</surname><given-names>C.</given-names></name>; <name><surname>Edqvist</surname><given-names>P. H.</given-names></name>; <name><surname>Olsson</surname><given-names>I.</given-names></name>; <name><surname>Rydberg</surname><given-names>U.</given-names></name>; <name><surname>Hudson</surname><given-names>P.</given-names></name>; <name><surname>Ottosson Takanen</surname><given-names>J.</given-names></name>; <name><surname>Berling</surname><given-names>H.</given-names></name>; <name><surname>Bjorling</surname><given-names>L.</given-names></name>; <name><surname>Tegel</surname><given-names>H.</given-names></name>; <name><surname>Rockberg</surname><given-names>J.</given-names></name>; <name><surname>Nilsson</surname><given-names>P.</given-names></name>; <name><surname>Navani</surname><given-names>S.</given-names></name>; <name><surname>Jirstrom</surname><given-names>K.</given-names></name>; <name><surname>Mulder</surname><given-names>J.</given-names></name>; <name><surname>Schwenk</surname><given-names>J. M.</given-names></name>; <name><surname>Zwahlen</surname><given-names>M.</given-names></name>; <name><surname>Hober</surname><given-names>S.</given-names></name>; <name><surname>Forsberg</surname><given-names>M.</given-names></name>; <name><surname>von Feilitzen</surname><given-names>K.</given-names></name>; <name><surname>Uhlen</surname><given-names>M.</given-names></name>
<article-title>Contribution of antibody-based protein profiling to the human Chromosome-Centric
Proteome Project (C-HPP)</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>12</volume><issue>6</issue><fpage>2439</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">23276153</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Dunham</surname><given-names>I.</given-names></name>; <name><surname>Shimizu</surname><given-names>N.</given-names></name>; <name><surname>Roe</surname><given-names>B. A.</given-names></name>; <name><surname>Chissoe</surname><given-names>S.</given-names></name>; <name><surname>Hunt</surname><given-names>A. R.</given-names></name>; <name><surname>Collins</surname><given-names>J. E.</given-names></name>; <name><surname>Bruskiewich</surname><given-names>R.</given-names></name>; <name><surname>Beare</surname><given-names>D. M.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Smink</surname><given-names>L. J.</given-names></name>; <name><surname>Ainscough</surname><given-names>R.</given-names></name>; <name><surname>Almeida</surname><given-names>J. P.</given-names></name>; <name><surname>Babbage</surname><given-names>A.</given-names></name>; <name><surname>Bagguley</surname><given-names>C.</given-names></name>; <name><surname>Bailey</surname><given-names>J.</given-names></name>; <name><surname>Barlow</surname><given-names>K.</given-names></name>; <name><surname>Bates</surname><given-names>K. N.</given-names></name>; <name><surname>Beasley</surname><given-names>O.</given-names></name>; <name><surname>Bird</surname><given-names>C. P.</given-names></name>; <name><surname>Blakey</surname><given-names>S.</given-names></name>; <name><surname>Bridgeman</surname><given-names>A. M.</given-names></name>; <name><surname>Buck</surname><given-names>D.</given-names></name>; <name><surname>Burgess</surname><given-names>J.</given-names></name>; <name><surname>Burrill</surname><given-names>W. D.</given-names></name>; <name><surname>O&#x02019;Brien</surname><given-names>K. P.</given-names></name>; et al. <article-title>The DNA sequence of
human chromosome 22</article-title>. <source>Nature</source>
<year>1999</year>, <volume>402</volume><issue>6761</issue><fpage>489</fpage>&#x02013;<lpage>495</lpage>.<pub-id pub-id-type="pmid">10591208</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Morton</surname><given-names>N. E.</given-names></name>
<article-title>Parameters
of the human genome</article-title>. <source>Proc. Natl. Acad. Sci.
U.S.A.</source>
<year>1991</year>, <volume>88</volume><issue>17</issue><fpage>7474</fpage>&#x02013;<lpage>7476</lpage>.<pub-id pub-id-type="pmid">1881886</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Wilson</surname><given-names>G. N.</given-names></name>; <name><surname>Baker</surname><given-names>D. L.</given-names></name>; <name><surname>Schau</surname><given-names>J.</given-names></name>; <name><surname>Parker</surname><given-names>J.</given-names></name>
<article-title>Cat eye syndrome owing
to tetrasomy 22pter leads to q11</article-title>. <source>J. Med. Genet</source>
<year>1984</year>, <volume>21</volume><issue>1</issue><fpage>60</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">6694188</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Driscoll</surname><given-names>D.
A.</given-names></name>; <name><surname>Budarf</surname><given-names>M. L.</given-names></name>; <name><surname>Emanuel</surname><given-names>B. S.</given-names></name>
<article-title>A genetic etiology for DiGeorge syndrome:
consistent deletions and microdeletions of 22q11</article-title>. <source>Am. J. Hum. Genet.</source>
<year>1992</year>, <volume>50</volume><issue>5</issue><fpage>924</fpage>&#x02013;<lpage>933</lpage>.<pub-id pub-id-type="pmid">1349199</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Shprintzen</surname><given-names>R. J.</given-names></name>; <name><surname>Goldberg</surname><given-names>R. B.</given-names></name>; <name><surname>Lewin</surname><given-names>M. L.</given-names></name>; <name><surname>Sidoti</surname><given-names>E. J.</given-names></name>; <name><surname>Berkman</surname><given-names>M. D.</given-names></name>; <name><surname>Argamaso</surname><given-names>R. V.</given-names></name>; <name><surname>Young</surname><given-names>D.</given-names></name>
<article-title>A new syndrome involving cleft palate,
cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial
syndrome</article-title>. <source>Cleft Palate J.</source>
<year>1978</year>, <volume>15</volume><issue>1</issue><fpage>56</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">272242</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Wong</surname><given-names>A. C.</given-names></name>; <name><surname>Ning</surname><given-names>Y.</given-names></name>; <name><surname>Flint</surname><given-names>J.</given-names></name>; <name><surname>Clark</surname><given-names>K.</given-names></name>; <name><surname>Dumanski</surname><given-names>J. P.</given-names></name>; <name><surname>Ledbetter</surname><given-names>D. H.</given-names></name>; <name><surname>McDermid</surname><given-names>H. E.</given-names></name>
<article-title>Molecular characterization of a 130-kb
terminal microdeletion at 22q in a child with mild mental retardation</article-title>. <source>Am. J. Hum. Genet.</source>
<year>1997</year>, <volume>60</volume><issue>1</issue><fpage>113</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">8981954</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Dreazen</surname><given-names>O.</given-names></name>; <name><surname>Klisak</surname><given-names>I.</given-names></name>; <name><surname>Jones</surname><given-names>G.</given-names></name>; <name><surname>Ho</surname><given-names>W. G.</given-names></name>; <name><surname>Sparkes</surname><given-names>R. S.</given-names></name>; <name><surname>Gale</surname><given-names>R. P.</given-names></name>
<article-title>Multiple molecular abnormalities in Ph1 chromosome
positive acute lymphoblastic leukaemia</article-title>. <source>Br.
J. Haematol.</source>
<year>1987</year>, <volume>67</volume><issue>3</issue><fpage>319</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">3479997</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="undeclared" id="cit14"><person-group person-group-type="allauthors"><name><surname>Kim</surname><given-names>M. S.</given-names></name>; <name><surname>Pinto</surname><given-names>S. M.</given-names></name>; <name><surname>Getnet</surname><given-names>D.</given-names></name>; <name><surname>Nirujogi</surname><given-names>R. S.</given-names></name>; <name><surname>Manda</surname><given-names>S. S.</given-names></name>; <name><surname>Chaerkady</surname><given-names>R.</given-names></name>; <name><surname>Madugundu</surname><given-names>A. K.</given-names></name>; <name><surname>Kelkar</surname><given-names>D. S.</given-names></name>; <name><surname>Isserlin</surname><given-names>R.</given-names></name>; <name><surname>Jain</surname><given-names>S.</given-names></name>; <name><surname>Thomas</surname><given-names>J. K.</given-names></name>; <name><surname>Muthusamy</surname><given-names>B.</given-names></name>; <name><surname>Leal-Rojas</surname><given-names>P.</given-names></name>; <name><surname>Kumar</surname><given-names>P.</given-names></name>; <name><surname>Sahasrabuddhe</surname><given-names>N. A.</given-names></name>; <name><surname>Balakrishnan</surname><given-names>L.</given-names></name>; <name><surname>Advani</surname><given-names>J.</given-names></name>; <name><surname>George</surname><given-names>B.</given-names></name>; <name><surname>Renuse</surname><given-names>S.</given-names></name>; <name><surname>Selvan</surname><given-names>L. D. N.</given-names></name>; <name><surname>Patil</surname><given-names>A. H.</given-names></name>; <name><surname>Nanjappa</surname><given-names>V.</given-names></name>; <name><surname>Radhakrishnan</surname><given-names>A.</given-names></name>; <name><surname>Prasad</surname><given-names>S.</given-names></name>; <name><surname>Subbannayya</surname><given-names>T.</given-names></name>; <name><surname>Raju</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>M.</given-names></name>; <name><surname>Sreenivasamurthy</surname><given-names>S. K.</given-names></name>; <name><surname>Marimuthu</surname><given-names>A.</given-names></name>; <name><surname>Sathe</surname><given-names>G. J.</given-names></name>; <name><surname>Chavan</surname><given-names>S.</given-names></name>; <name><surname>Datta</surname><given-names>K. K.</given-names></name>; <name><surname>Subbannayya</surname><given-names>Y.</given-names></name>; <name><surname>Sahu</surname><given-names>A.</given-names></name>; <name><surname>Yelamanchi</surname><given-names>S. D.</given-names></name>; <name><surname>Jayaram</surname><given-names>S.</given-names></name>; <name><surname>Rajagopalan</surname><given-names>P.</given-names></name>; <name><surname>Sharma</surname><given-names>J.</given-names></name>; <name><surname>Murthy</surname><given-names>K. R.</given-names></name>; <name><surname>Syed</surname><given-names>N.</given-names></name>; <name><surname>Goel</surname><given-names>R.</given-names></name>; <name><surname>Khan</surname><given-names>A. K.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>; <name><surname>Dey</surname><given-names>G.</given-names></name>; <name><surname>Mudgal</surname><given-names>K.</given-names></name>; <name><surname>Chatterjee</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>T.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>X.</given-names></name>; <name><surname>Shaw</surname><given-names>P. G.</given-names></name>; <name><surname>Freed</surname><given-names>D.</given-names></name>; <name><surname>Zahari</surname><given-names>M. S.</given-names></name>; <name><surname>Mukherjee</surname><given-names>K. K.</given-names></name>; <name><surname>Shankar</surname><given-names>S.</given-names></name>; <name><surname>Mahadevan</surname><given-names>A.</given-names></name>; <name><surname>Lam</surname><given-names>H.</given-names></name>; <name><surname>Mitchell</surname><given-names>C. J.</given-names></name>; <name><surname>Shankar</surname><given-names>S. K.</given-names></name>; <name><surname>Satishchandra</surname><given-names>P.</given-names></name>; <name><surname>Schroeder</surname><given-names>J. T.</given-names></name>; <name><surname>Sirdeshmukh</surname><given-names>R.</given-names></name>; <name><surname>Maitra</surname><given-names>A.</given-names></name>; <name><surname>Leach</surname><given-names>S. D.</given-names></name>; <name><surname>Drake</surname><given-names>C. G.</given-names></name>; <name><surname>Halushka</surname><given-names>M. K.</given-names></name>; <name><surname>Prasad</surname><given-names>T. S. K.</given-names></name>; <name><surname>Hruban</surname><given-names>R. H.</given-names></name>; <name><surname>Kerr</surname><given-names>C. L.</given-names></name>; <name><surname>Bader</surname><given-names>G. D.</given-names></name>; <name><surname>Iacobuzio-Donahue</surname><given-names>C.
H.</given-names></name>; <name><surname>Gowda</surname><given-names>H.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name></person-group><article-title>A draft map of the human proteome</article-title>. <source>Nature</source><year>2014</year>, In press</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Harsha</surname><given-names>H. C.</given-names></name>; <name><surname>Molina</surname><given-names>H.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>Quantitative proteomics using stable
isotope labeling with amino acids in cell culture</article-title>. <source>Nat. Protoc.</source>
<year>2008</year>, <volume>3</volume><issue>3</issue><fpage>505</fpage>&#x02013;<lpage>516</lpage>.<pub-id pub-id-type="pmid">18323819</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Kall</surname><given-names>L.</given-names></name>; <name><surname>Canterbury</surname><given-names>J. D.</given-names></name>; <name><surname>Weston</surname><given-names>J.</given-names></name>; <name><surname>Noble</surname><given-names>W. S.</given-names></name>; <name><surname>MacCoss</surname><given-names>M. J.</given-names></name>
<article-title>Semi-supervised
learning for peptide identification from shotgun proteomics datasets</article-title>. <source>Nat. Methods</source>
<year>2007</year>, <volume>4</volume><issue>11</issue><fpage>923</fpage>&#x02013;<lpage>925</lpage>.<pub-id pub-id-type="pmid">17952086</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Keshava
Prasad</surname><given-names>T. S.</given-names></name>; <name><surname>Goel</surname><given-names>R.</given-names></name>; <name><surname>Kandasamy</surname><given-names>K.</given-names></name>; <name><surname>Keerthikumar</surname><given-names>S.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Mathivanan</surname><given-names>S.</given-names></name>; <name><surname>Telikicherla</surname><given-names>D.</given-names></name>; <name><surname>Raju</surname><given-names>R.</given-names></name>; <name><surname>Shafreen</surname><given-names>B.</given-names></name>; <name><surname>Venugopal</surname><given-names>A.</given-names></name>; <name><surname>Balakrishnan</surname><given-names>L.</given-names></name>; <name><surname>Marimuthu</surname><given-names>A.</given-names></name>; <name><surname>Banerjee</surname><given-names>S.</given-names></name>; <name><surname>Somanathan</surname><given-names>D. S.</given-names></name>; <name><surname>Sebastian</surname><given-names>A.</given-names></name>; <name><surname>Rani</surname><given-names>S.</given-names></name>; <name><surname>Ray</surname><given-names>S.</given-names></name>; <name><surname>Harrys Kishore</surname><given-names>C. J.</given-names></name>; <name><surname>Kanth</surname><given-names>S.</given-names></name>; <name><surname>Ahmed</surname><given-names>M.</given-names></name>; <name><surname>Kashyap</surname><given-names>M. K.</given-names></name>; <name><surname>Mohmood</surname><given-names>R.</given-names></name>; <name><surname>Ramachandra</surname><given-names>Y. L.</given-names></name>; <name><surname>Krishna</surname><given-names>V.</given-names></name>; <name><surname>Rahiman</surname><given-names>B. A.</given-names></name>; <name><surname>Mohan</surname><given-names>S.</given-names></name>; <name><surname>Ranganathan</surname><given-names>P.</given-names></name>; <name><surname>Ramabadran</surname><given-names>S.</given-names></name>; <name><surname>Chaerkady</surname><given-names>R.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>Human Protein Reference Database--2009 update</article-title>. <source>Nucleic Acids Res.</source>
<year>2009</year>, <volume>37</volume><issue>Database issue</issue><fpage>D767</fpage>&#x02013;<lpage>D772</lpage>.<pub-id pub-id-type="pmid">18988627</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Chu</surname><given-names>H.</given-names></name>; <name><surname>Thievessen</surname><given-names>I.</given-names></name>; <name><surname>Sixt</surname><given-names>M.</given-names></name>; <name><surname>Lammermann</surname><given-names>T.</given-names></name>; <name><surname>Waisman</surname><given-names>A.</given-names></name>; <name><surname>Braun</surname><given-names>A.</given-names></name>; <name><surname>Noegel</surname><given-names>A. A.</given-names></name>; <name><surname>Fassler</surname><given-names>R.</given-names></name>
<article-title>Gamma-Parvin
is dispensable for hematopoiesis, leukocyte trafficking, and T-cell-dependent
antibody response</article-title>. <source>Mol. Cell. Biol.</source>
<year>2006</year>, <volume>26</volume><issue>5</issue><fpage>1817</fpage>&#x02013;<lpage>1825</lpage>.<pub-id pub-id-type="pmid">16479001</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Marko-Varga</surname><given-names>G.</given-names></name>; <name><surname>Omenn</surname><given-names>G. S.</given-names></name>; <name><surname>Paik</surname><given-names>Y. K.</given-names></name>; <name><surname>Hancock</surname><given-names>W. S.</given-names></name>
<article-title>A first step toward
completion of a genome-wide characterization of the human proteome</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>12</volume><issue>1</issue><fpage>1</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">23256439</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Veenman</surname><given-names>L.</given-names></name>; <name><surname>Papadopoulos</surname><given-names>V.</given-names></name>; <name><surname>Gavish</surname><given-names>M.</given-names></name>
<article-title>Channel-like functions of the 18-kDa
translocator protein (TSPO): regulation of apoptosis and steroidogenesis
as part of the host-defense response</article-title>. <source>Curr.
Pharm. Des</source>
<year>2007</year>, <volume>13</volume><issue>23</issue><fpage>2385</fpage>&#x02013;<lpage>2405</lpage>.<pub-id pub-id-type="pmid">17692008</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Footz</surname><given-names>T. K.</given-names></name>; <name><surname>Brinkman-Mills</surname><given-names>P.</given-names></name>; <name><surname>Banting</surname><given-names>G. S.</given-names></name>; <name><surname>Maier</surname><given-names>S. A.</given-names></name>; <name><surname>Riazi</surname><given-names>M. A.</given-names></name>; <name><surname>Bridgland</surname><given-names>L.</given-names></name>; <name><surname>Hu</surname><given-names>S.</given-names></name>; <name><surname>Birren</surname><given-names>B.</given-names></name>; <name><surname>Minoshima</surname><given-names>S.</given-names></name>; <name><surname>Shimizu</surname><given-names>N.</given-names></name>; <name><surname>Pan</surname><given-names>H.</given-names></name>; <name><surname>Nguyen</surname><given-names>T.</given-names></name>; <name><surname>Fang</surname><given-names>F.</given-names></name>; <name><surname>Fu</surname><given-names>Y.</given-names></name>; <name><surname>Ray</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Shaull</surname><given-names>S.</given-names></name>; <name><surname>Phan</surname><given-names>S.</given-names></name>; <name><surname>Yao</surname><given-names>Z.</given-names></name>; <name><surname>Chen</surname><given-names>F.</given-names></name>; <name><surname>Huan</surname><given-names>A.</given-names></name>; <name><surname>Hu</surname><given-names>P.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Loh</surname><given-names>P.</given-names></name>; <name><surname>Qi</surname><given-names>S.</given-names></name>; <name><surname>Roe</surname><given-names>B. A.</given-names></name>; <name><surname>McDermid</surname><given-names>H. E.</given-names></name>
<article-title>Analysis of the
cat eye syndrome critical region in humans and the region of conserved
synteny in mice: a search for candidate genes at or near the human
chromosome 22 pericentromere</article-title>. <source>Genome Res.</source>
<year>2001</year>, <volume>11</volume><issue>6</issue><fpage>1053</fpage>&#x02013;<lpage>1070</lpage>.<pub-id pub-id-type="pmid">11381032</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Mittelstaedt</surname><given-names>T.</given-names></name>; <name><surname>Schoch</surname><given-names>S.</given-names></name>
<article-title>Structure
and evolution of RIM-BP genes: identification
of a novel family member</article-title>. <source>Gene</source>
<year>2007</year>, <volume>403</volume><issue>1&#x02013;2</issue><fpage>70</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">17855024</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Frippiat</surname><given-names>J.
P.</given-names></name>; <name><surname>Williams</surname><given-names>S. C.</given-names></name>; <name><surname>Tomlinson</surname><given-names>I. M.</given-names></name>; <name><surname>Cook</surname><given-names>G. P.</given-names></name>; <name><surname>Cherif</surname><given-names>D.</given-names></name>; <name><surname>Le Paslier</surname><given-names>D.</given-names></name>; <name><surname>Collins</surname><given-names>J. E.</given-names></name>; <name><surname>Dunham</surname><given-names>I.</given-names></name>; <name><surname>Winter</surname><given-names>G.</given-names></name>; <name><surname>Lefranc</surname><given-names>M. P.</given-names></name>
<article-title>Organization
of the human immunoglobulin lambda light-chain
locus on chromosome 22q11.2</article-title>. <source>Hum. Mol. Genet.</source>
<year>1995</year>, <volume>4</volume><issue>6</issue><fpage>983</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">7655473</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Morris</surname><given-names>C.</given-names></name>; <name><surname>Courtay</surname><given-names>C.</given-names></name>; <name><surname>Geurts van
Kessel</surname><given-names>A.</given-names></name>; <name><surname>ten Hoeve</surname><given-names>J.</given-names></name>; <name><surname>Heisterkamp</surname><given-names>N.</given-names></name>; <name><surname>Groffen</surname><given-names>J.</given-names></name>
<article-title>Localization of a gamma-glutamyl-transferase-related
gene family on chromosome 22</article-title>. <source>Hum. Genet.</source>
<year>1993</year>, <volume>91</volume><issue>1</issue><fpage>31</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">8095916</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Seroussi</surname><given-names>E.</given-names></name>; <name><surname>Kedra</surname><given-names>D.</given-names></name>; <name><surname>Pan</surname><given-names>H. Q.</given-names></name>; <name><surname>Peyrard</surname><given-names>M.</given-names></name>; <name><surname>Schwartz</surname><given-names>C.</given-names></name>; <name><surname>Scambler</surname><given-names>P.</given-names></name>; <name><surname>Donnai</surname><given-names>D.</given-names></name>; <name><surname>Roe</surname><given-names>B. A.</given-names></name>; <name><surname>Dumanski</surname><given-names>J. P.</given-names></name>
<article-title>Duplications
on human chromosome 22 reveal a novel Ret Finger Protein-like gene
family with sense and endogenous antisense transcripts</article-title>. <source>Genome Res.</source>
<year>1999</year>, <volume>9</volume><issue>9</issue><fpage>803</fpage>&#x02013;<lpage>814</lpage>.<pub-id pub-id-type="pmid">10508838</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Duchateau</surname><given-names>P. N.</given-names></name>; <name><surname>Pullinger</surname><given-names>C. R.</given-names></name>; <name><surname>Cho</surname><given-names>M. H.</given-names></name>; <name><surname>Eng</surname><given-names>C.</given-names></name>; <name><surname>Kane</surname><given-names>J. P.</given-names></name>
<article-title>Apolipoprotein
L gene family: tissue-specific expression, splicing, promoter regions;
discovery of a new gene</article-title>. <source>J. Lipid Res.</source>
<year>2001</year>, <volume>42</volume><issue>4</issue><fpage>620</fpage>&#x02013;<lpage>630</lpage>.<pub-id pub-id-type="pmid">11290834</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Bijlsma</surname><given-names>E.
K.</given-names></name>; <name><surname>Delattre</surname><given-names>O.</given-names></name>; <name><surname>Juyn</surname><given-names>J. A.</given-names></name>; <name><surname>Melot</surname><given-names>T.</given-names></name>; <name><surname>Westerveld</surname><given-names>A.</given-names></name>; <name><surname>Dumanski</surname><given-names>J. P.</given-names></name>; <name><surname>Thomas</surname><given-names>G.</given-names></name>; <name><surname>Hulsebos</surname><given-names>T. J.</given-names></name>
<article-title>Regional fine mapping
of the beta Crystallin genes on chromosome 22 excludes these genes
as physically linked markers for neurofibromatosis type 2</article-title>. <source>Genes, Chromosomes Cancer</source>
<year>1993</year>, <volume>8</volume><issue>2</issue><fpage>112</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">7504514</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Hulsebos</surname><given-names>T. J.</given-names></name>; <name><surname>Jenkins</surname><given-names>N. A.</given-names></name>; <name><surname>Gilbert</surname><given-names>D. J.</given-names></name>; <name><surname>Copeland</surname><given-names>N. G.</given-names></name>
<article-title>The beta Crystallin
genes on human chromosome 22 define a new region of homology with
mouse chromosome 5</article-title>. <source>Genomics</source>
<year>1995</year>, <volume>25</volume><issue>2</issue><fpage>574</fpage>&#x02013;<lpage>576</lpage>.<pub-id pub-id-type="pmid">7789995</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Jarmuz</surname><given-names>A.</given-names></name>; <name><surname>Chester</surname><given-names>A.</given-names></name>; <name><surname>Bayliss</surname><given-names>J.</given-names></name>; <name><surname>Gisbourne</surname><given-names>J.</given-names></name>; <name><surname>Dunham</surname><given-names>I.</given-names></name>; <name><surname>Scott</surname><given-names>J.</given-names></name>; <name><surname>Navaratnam</surname><given-names>N.</given-names></name>
<article-title>An anthropoid-specific
locus of orphan C to U RNA-editing enzymes on chromosome 22</article-title>. <source>Genomics</source>
<year>2002</year>, <volume>79</volume><issue>3</issue><fpage>285</fpage>&#x02013;<lpage>296</lpage>.<pub-id pub-id-type="pmid">11863358</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Cullen</surname><given-names>B. R.</given-names></name>
<article-title>Role and
mechanism of action of the APOBEC3 family of antiretroviral resistance
factors</article-title>. <source>J. Virol</source>
<year>2006</year>, <volume>80</volume><issue>3</issue><fpage>1067</fpage>&#x02013;<lpage>1076</lpage>.<pub-id pub-id-type="pmid">16414984</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Lackey</surname><given-names>L.</given-names></name>; <name><surname>Law</surname><given-names>E. K.</given-names></name>; <name><surname>Brown</surname><given-names>W. L.</given-names></name>; <name><surname>Harris</surname><given-names>R. S.</given-names></name>
<article-title>Subcellular localization
of the APOBEC3 proteins during mitosis and implications for genomic
DNA deamination</article-title>. <source>Cell Cycle</source>
<year>2013</year>, <volume>12</volume><issue>5</issue><fpage>762</fpage>&#x02013;<lpage>772</lpage>.<pub-id pub-id-type="pmid">23388464</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Navaratnam</surname><given-names>N.</given-names></name>; <name><surname>Morrison</surname><given-names>J. R.</given-names></name>; <name><surname>Bhattacharya</surname><given-names>S.</given-names></name>; <name><surname>Patel</surname><given-names>D.</given-names></name>; <name><surname>Funahashi</surname><given-names>T.</given-names></name>; <name><surname>Giannoni</surname><given-names>F.</given-names></name>; <name><surname>Teng</surname><given-names>B. B.</given-names></name>; <name><surname>Davidson</surname><given-names>N. O.</given-names></name>; <name><surname>Scott</surname><given-names>J.</given-names></name>
<article-title>The p27 catalytic
subunit of the apolipoprotein B mRNA editing enzyme is a cytidine
deaminase</article-title>. <source>J. Biol. Chem.</source>
<year>1993</year>, <volume>268</volume><issue>28</issue><fpage>20709</fpage>&#x02013;<lpage>20712</lpage>.<pub-id pub-id-type="pmid">8407891</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Teng</surname><given-names>B.</given-names></name>; <name><surname>Burant</surname><given-names>C. F.</given-names></name>; <name><surname>Davidson</surname><given-names>N. O.</given-names></name>
<article-title>Molecular
cloning of an apolipoprotein
B messenger RNA editing protein</article-title>. <source>Science</source>
<year>1993</year>, <volume>260</volume><issue>5115</issue><fpage>1816</fpage>&#x02013;<lpage>1819</lpage>.<pub-id pub-id-type="pmid">8511591</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Dang</surname><given-names>Y.</given-names></name>; <name><surname>Siew</surname><given-names>L. M.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Han</surname><given-names>Y.</given-names></name>; <name><surname>Lampen</surname><given-names>R.</given-names></name>; <name><surname>Zheng</surname><given-names>Y. H.</given-names></name>
<article-title>Human cytidine deaminase APOBEC3H
restricts HIV-1 replication</article-title>. <source>J. Biol. Chem.</source>
<year>2008</year>, <volume>283</volume><issue>17</issue><fpage>11606</fpage>&#x02013;<lpage>11614</lpage>.<pub-id pub-id-type="pmid">18299330</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Seng</surname><given-names>T. J.</given-names></name>; <name><surname>Ichimura</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Tingby</surname><given-names>O.</given-names></name>; <name><surname>Pearson</surname><given-names>D. M.</given-names></name>; <name><surname>Collins</surname><given-names>V. P.</given-names></name>
<article-title>Complex chromosome
22 rearrangements in astrocytic
tumors identified using microsatellite and chromosome 22 tile path
array analysis</article-title>. <source>Genes, Chromosomes Cancer</source>
<year>2005</year>, <volume>43</volume><issue>2</issue><fpage>181</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">15770670</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Tsilchorozidou</surname><given-names>T.</given-names></name>; <name><surname>Menko</surname><given-names>F. H.</given-names></name>; <name><surname>Lalloo</surname><given-names>F.</given-names></name>; <name><surname>Kidd</surname><given-names>A.</given-names></name>; <name><surname>De Silva</surname><given-names>R.</given-names></name>; <name><surname>Thomas</surname><given-names>H.</given-names></name>; <name><surname>Smith</surname><given-names>P.</given-names></name>; <name><surname>Malcolmson</surname><given-names>A.</given-names></name>; <name><surname>Dore</surname><given-names>J.</given-names></name>; <name><surname>Madan</surname><given-names>K.</given-names></name>; <name><surname>Brown</surname><given-names>A.</given-names></name>; <name><surname>Yovos</surname><given-names>J. G.</given-names></name>; <name><surname>Tsaligopoulos</surname><given-names>M.</given-names></name>; <name><surname>Vogiatzis</surname><given-names>N.</given-names></name>; <name><surname>Baser</surname><given-names>M. E.</given-names></name>; <name><surname>Wallace</surname><given-names>A. J.</given-names></name>; <name><surname>Evans</surname><given-names>D. G.</given-names></name>
<article-title>Constitutional
rearrangements of chromosome 22 as a
cause of neurofibromatosis 2</article-title>. <source>J. Med. Genet</source>
<year>2004</year>, <volume>41</volume><issue>7</issue><fpage>529</fpage>&#x02013;<lpage>534</lpage>.<pub-id pub-id-type="pmid">15235024</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Im</surname><given-names>H.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Cristofanilli</surname><given-names>M.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>; <name><surname>Deutsch</surname><given-names>E. W.</given-names></name>; <name><surname>Dalton</surname><given-names>S.</given-names></name>; <name><surname>Fenyo</surname><given-names>D.</given-names></name>; <name><surname>Fanayan</surname><given-names>S.</given-names></name>; <name><surname>Gates</surname><given-names>C.</given-names></name>; <name><surname>Gaudet</surname><given-names>P.</given-names></name>; <name><surname>Hincapie</surname><given-names>M.</given-names></name>; <name><surname>Hanash</surname><given-names>S.</given-names></name>; <name><surname>Kim</surname><given-names>H.</given-names></name>; <name><surname>Jeong</surname><given-names>S. K.</given-names></name>; <name><surname>Lundberg</surname><given-names>E.</given-names></name>; <name><surname>Mias</surname><given-names>G.</given-names></name>; <name><surname>Menon</surname><given-names>R.</given-names></name>; <name><surname>Mu</surname><given-names>Z.</given-names></name>; <name><surname>Nice</surname><given-names>E.</given-names></name>; <name><surname>Paik</surname><given-names>Y. K.</given-names></name>; <name><surname>Uhlen</surname><given-names>M.</given-names></name>; <name><surname>Wells</surname><given-names>L.</given-names></name>; <name><surname>Wu</surname><given-names>S. L.</given-names></name>; <name><surname>Yan</surname><given-names>F.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Snyder</surname><given-names>M.</given-names></name>; <name><surname>Omenn</surname><given-names>G. S.</given-names></name>; <name><surname>Beavis</surname><given-names>R. C.</given-names></name>; <name><surname>Hancock</surname><given-names>W. S.</given-names></name>
<article-title>A chromosome-centric
human proteome project (C-HPP) to characterize the sets of proteins
encoded in chromosome 17</article-title>. <source>J. Proteome Res.</source>
<year>2013</year>, <volume>12</volume><issue>1</issue><fpage>45</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">23259914</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Shaw</surname><given-names>R. J.</given-names></name>; <name><surname>Paez</surname><given-names>J. G.</given-names></name>; <name><surname>Curto</surname><given-names>M.</given-names></name>; <name><surname>Yaktine</surname><given-names>A.</given-names></name>; <name><surname>Pruitt</surname><given-names>W. M.</given-names></name>; <name><surname>Saotome</surname><given-names>I.</given-names></name>; <name><surname>O&#x02019;Bryan</surname><given-names>J. P.</given-names></name>; <name><surname>Gupta</surname><given-names>V.</given-names></name>; <name><surname>Ratner</surname><given-names>N.</given-names></name>; <name><surname>Der</surname><given-names>C. J.</given-names></name>; <name><surname>Jacks</surname><given-names>T.</given-names></name>; <name><surname>McClatchey</surname><given-names>A. I.</given-names></name>
<article-title>The Nf2
tumor suppressor, merlin, functions in Rac-dependent signaling</article-title>. <source>Dev. Cell</source>
<year>2001</year>, <volume>1</volume><issue>1</issue><fpage>63</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">11703924</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Morrison</surname><given-names>H.</given-names></name>; <name><surname>Sperka</surname><given-names>T.</given-names></name>; <name><surname>Manent</surname><given-names>J.</given-names></name>; <name><surname>Giovannini</surname><given-names>M.</given-names></name>; <name><surname>Ponta</surname><given-names>H.</given-names></name>; <name><surname>Herrlich</surname><given-names>P.</given-names></name>
<article-title>Merlin/neurofibromatosis type 2 suppresses
growth by inhibiting the activation of Ras and Rac</article-title>. <source>Cancer Res.</source>
<year>2007</year>, <volume>67</volume><issue>2</issue><fpage>520</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">17234759</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>James</surname><given-names>M. F.</given-names></name>; <name><surname>Han</surname><given-names>S.</given-names></name>; <name><surname>Polizzano</surname><given-names>C.</given-names></name>; <name><surname>Plotkin</surname><given-names>S. R.</given-names></name>; <name><surname>Manning</surname><given-names>B. D.</given-names></name>; <name><surname>Stemmer-Rachamimov</surname><given-names>A. O.</given-names></name>; <name><surname>Gusella</surname><given-names>J. F.</given-names></name>; <name><surname>Ramesh</surname><given-names>V.</given-names></name>
<article-title>NF2/merlin is a novel negative regulator
of mTOR complex 1, and activation of mTORC1 is associated with meningioma
and schwannoma growth</article-title>. <source>Mol. Cell. Biol.</source>
<year>2009</year>, <volume>29</volume><issue>15</issue><fpage>4250</fpage>&#x02013;<lpage>4261</lpage>.<pub-id pub-id-type="pmid">19451225</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Hamaratoglu</surname><given-names>F.</given-names></name>; <name><surname>Willecke</surname><given-names>M.</given-names></name>; <name><surname>Kango-Singh</surname><given-names>M.</given-names></name>; <name><surname>Nolo</surname><given-names>R.</given-names></name>; <name><surname>Hyun</surname><given-names>E.</given-names></name>; <name><surname>Tao</surname><given-names>C.</given-names></name>; <name><surname>Jafar-Nejad</surname><given-names>H.</given-names></name>; <name><surname>Halder</surname><given-names>G.</given-names></name>
<article-title>The tumour-suppressor genes NF2/Merlin
and Expanded act through Hippo signalling to regulate cell proliferation
and apoptosis</article-title>. <source>Nat. Cell Biol.</source>
<year>2006</year>, <volume>8</volume><issue>1</issue><fpage>27</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">16341207</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Rouleau</surname><given-names>G. A.</given-names></name>; <name><surname>Merel</surname><given-names>P.</given-names></name>; <name><surname>Lutchman</surname><given-names>M.</given-names></name>; <name><surname>Sanson</surname><given-names>M.</given-names></name>; <name><surname>Zucman</surname><given-names>J.</given-names></name>; <name><surname>Marineau</surname><given-names>C.</given-names></name>; <name><surname>Hoang-Xuan</surname><given-names>K.</given-names></name>; <name><surname>Demczuk</surname><given-names>S.</given-names></name>; <name><surname>Desmaze</surname><given-names>C.</given-names></name>; <name><surname>Plougastel</surname><given-names>B.</given-names></name>; et al. <article-title>Alteration in a new gene encoding a putative
membrane-organizing protein causes neuro-fibromatosis type 2</article-title>. <source>Nature</source>
<year>1993</year>, <volume>363</volume><issue>6429</issue><fpage>515</fpage>&#x02013;<lpage>521</lpage>.<pub-id pub-id-type="pmid">8379998</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Trofatter</surname><given-names>J. A.</given-names></name>; <name><surname>MacCollin</surname><given-names>M. M.</given-names></name>; <name><surname>Rutter</surname><given-names>J. L.</given-names></name>; <name><surname>Murrell</surname><given-names>J. R.</given-names></name>; <name><surname>Duyao</surname><given-names>M. P.</given-names></name>; <name><surname>Parry</surname><given-names>D. M.</given-names></name>; <name><surname>Eldridge</surname><given-names>R.</given-names></name>; <name><surname>Kley</surname><given-names>N.</given-names></name>; <name><surname>Menon</surname><given-names>A. G.</given-names></name>; <name><surname>Pulaski</surname><given-names>K.</given-names></name>; et al. <article-title>A novel moesin-, ezrin-, radixin-like gene is a candidate
for the neurofibromatosis 2 tumor suppressor</article-title>. <source>Cell</source>
<year>1993</year>, <volume>72</volume><issue>5</issue><fpage>791</fpage>&#x02013;<lpage>800</lpage>.<pub-id pub-id-type="pmid">8453669</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Zucman-Rossi</surname><given-names>J.</given-names></name>; <name><surname>Legoix</surname><given-names>P.</given-names></name>; <name><surname>Thomas</surname><given-names>G.</given-names></name>
<article-title>Identification of new members of
the Gas2 and Ras families in the 22q12 chromosome region</article-title>. <source>Genomics</source>
<year>1996</year>, <volume>38</volume><issue>3</issue><fpage>247</fpage>&#x02013;<lpage>254</lpage>.<pub-id pub-id-type="pmid">8975699</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Pandey</surname><given-names>A.</given-names></name>; <name><surname>Mann</surname><given-names>M.</given-names></name>
<article-title>Proteomics to study genes and genomes</article-title>. <source>Nature</source>
<year>2000</year>, <volume>405</volume><issue>6788</issue><fpage>837</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">10866210</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Chaerkady</surname><given-names>R.</given-names></name>; <name><surname>Kelkar</surname><given-names>D. S.</given-names></name>; <name><surname>Muthusamy</surname><given-names>B.</given-names></name>; <name><surname>Kandasamy</surname><given-names>K.</given-names></name>; <name><surname>Dwivedi</surname><given-names>S. B.</given-names></name>; <name><surname>Sahasrabuddhe</surname><given-names>N. A.</given-names></name>; <name><surname>Kim</surname><given-names>M. S.</given-names></name>; <name><surname>Renuse</surname><given-names>S.</given-names></name>; <name><surname>Pinto</surname><given-names>S. M.</given-names></name>; <name><surname>Sharma</surname><given-names>R.</given-names></name>; <name><surname>Pawar</surname><given-names>H.</given-names></name>; <name><surname>Sekhar</surname><given-names>N. R.</given-names></name>; <name><surname>Mohanty</surname><given-names>A. K.</given-names></name>; <name><surname>Getnet</surname><given-names>D.</given-names></name>; <name><surname>Yang</surname><given-names>Y.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>; <name><surname>Dash</surname><given-names>A. P.</given-names></name>; <name><surname>MacCallum</surname><given-names>R. M.</given-names></name>; <name><surname>Delanghe</surname><given-names>B.</given-names></name>; <name><surname>Mlambo</surname><given-names>G.</given-names></name>; <name><surname>Kumar</surname><given-names>A.</given-names></name>; <name><surname>Keshava
Prasad</surname><given-names>T. S.</given-names></name>; <name><surname>Okulate</surname><given-names>M.</given-names></name>; <name><surname>Kumar</surname><given-names>N.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>A proteogenomic
analysis of Anopheles gambiae using
high-resolution Fourier transform mass spectrometry</article-title>. <source>Genome Res.</source>
<year>2011</year>, <volume>21</volume><issue>11</issue><fpage>1872</fpage>&#x02013;<lpage>1881</lpage>.<pub-id pub-id-type="pmid">21795387</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Kelkar</surname><given-names>D. S.</given-names></name>; <name><surname>Kumar</surname><given-names>D.</given-names></name>; <name><surname>Kumar</surname><given-names>P.</given-names></name>; <name><surname>Balakrishnan</surname><given-names>L.</given-names></name>; <name><surname>Muthusamy</surname><given-names>B.</given-names></name>; <name><surname>Yadav</surname><given-names>A. K.</given-names></name>; <name><surname>Shrivastava</surname><given-names>P.</given-names></name>; <name><surname>Marimuthu</surname><given-names>A.</given-names></name>; <name><surname>Anand</surname><given-names>S.</given-names></name>; <name><surname>Sundaram</surname><given-names>H.</given-names></name>; <name><surname>Kingsbury</surname><given-names>R.</given-names></name>; <name><surname>Harsha</surname><given-names>H. C.</given-names></name>; <name><surname>Nair</surname><given-names>B.</given-names></name>; <name><surname>Prasad</surname><given-names>T. S.</given-names></name>; <name><surname>Chauhan</surname><given-names>D. S.</given-names></name>; <name><surname>Katoch</surname><given-names>K.</given-names></name>; <name><surname>Katoch</surname><given-names>V. M.</given-names></name>; <name><surname>Chaerkady</surname><given-names>R.</given-names></name>; <name><surname>Ramachandran</surname><given-names>S.</given-names></name>; <name><surname>Dash</surname><given-names>D.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>Proteogenomic analysis
of Mycobacterium tuberculosis by high resolution mass spectrometry</article-title>. <source>Mol. Cell Proteomics</source>
<year>2011</year>, <volume>10</volume><issue>12</issue><elocation-id>10.1074/mcp.M111.011627</elocation-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Pawar</surname><given-names>H.</given-names></name>; <name><surname>Sahasrabuddhe</surname><given-names>N. A.</given-names></name>; <name><surname>Renuse</surname><given-names>S.</given-names></name>; <name><surname>Keerthikumar</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>J.</given-names></name>; <name><surname>Kumar</surname><given-names>G. S.</given-names></name>; <name><surname>Venugopal</surname><given-names>A.</given-names></name>; <name><surname>Sekhar</surname><given-names>N. R.</given-names></name>; <name><surname>Kelkar</surname><given-names>D. S.</given-names></name>; <name><surname>Nemade</surname><given-names>H.</given-names></name>; <name><surname>Khobragade</surname><given-names>S. N.</given-names></name>; <name><surname>Muthusamy</surname><given-names>B.</given-names></name>; <name><surname>Kandasamy</surname><given-names>K.</given-names></name>; <name><surname>Harsha</surname><given-names>H. C.</given-names></name>; <name><surname>Chaerkady</surname><given-names>R.</given-names></name>; <name><surname>Patole</surname><given-names>M. S.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>A proteogenomic
approach to map the
proteome of an unsequenced pathogen - Leishmania donovani</article-title>. <source>Proteomics</source>
<year>2012</year>, <volume>12</volume><issue>6</issue><fpage>832</fpage>&#x02013;<lpage>844</lpage>.<pub-id pub-id-type="pmid">22539434</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Calvo</surname><given-names>S. E.</given-names></name>; <name><surname>Pagliarini</surname><given-names>D. J.</given-names></name>; <name><surname>Mootha</surname><given-names>V. K.</given-names></name>
<article-title>Upstream open reading frames cause
widespread reduction of protein expression and are polymorphic among
humans</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<year>2009</year>, <volume>106</volume><issue>18</issue><fpage>7507</fpage>&#x02013;<lpage>7512</lpage>.<pub-id pub-id-type="pmid">19372376</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Peri</surname><given-names>S.</given-names></name>; <name><surname>Pandey</surname><given-names>A.</given-names></name>
<article-title>A reassessment of the
translation initiation codon
in vertebrates</article-title>. <source>Trends Genet</source>
<year>2001</year>, <volume>17</volume><issue>12</issue><fpage>685</fpage>&#x02013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">11718907</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Yamashita</surname><given-names>R.</given-names></name>; <name><surname>Suzuki</surname><given-names>Y.</given-names></name>; <name><surname>Nakai</surname><given-names>K.</given-names></name>; <name><surname>Sugano</surname><given-names>S.</given-names></name>
<article-title>Small open reading
frames in 5&#x02032; untranslated regions of mRNAs</article-title>. <source>C R Biol.</source>
<year>2003</year>, <volume>326</volume><issue>10&#x02013;11</issue><fpage>987</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">14744105</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>T.</given-names></name>; <name><surname>Jin</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Qu</surname><given-names>M.</given-names></name>; <name><surname>Uhlen</surname><given-names>P.</given-names></name>; <name><surname>Tomilin</surname><given-names>N.</given-names></name>; <name><surname>Shupliakov</surname><given-names>O.</given-names></name>; <name><surname>Lendahl</surname><given-names>U.</given-names></name>; <name><surname>Nister</surname><given-names>M.</given-names></name>
<article-title>Human MIEF1
recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial
fusion rather than fission</article-title>. <source>EMBO J.</source>
<year>2011</year>, <volume>30</volume><issue>14</issue><fpage>2762</fpage>&#x02013;<lpage>2778</lpage>.<pub-id pub-id-type="pmid">21701560</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Palmer</surname><given-names>C.
S.</given-names></name>; <name><surname>Elgass</surname><given-names>K. D.</given-names></name>; <name><surname>Parton</surname><given-names>R. G.</given-names></name>; <name><surname>Osellame</surname><given-names>L. D.</given-names></name>; <name><surname>Stojanovski</surname><given-names>D.</given-names></name>; <name><surname>Ryan</surname><given-names>M. T.</given-names></name>
<article-title>Adaptor proteins MiD49 and MiD51 can act independently
of Mff and Fis1 in Drp1 recruitment and are specific for mitochondrial
fission</article-title>. <source>J. Biol. Chem.</source>
<year>2013</year>, <volume>288</volume><issue>38</issue><fpage>27584</fpage>&#x02013;<lpage>27593</lpage>.<pub-id pub-id-type="pmid">23921378</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Vizcaino</surname><given-names>J. A.</given-names></name>; <name><surname>Cote</surname><given-names>R. G.</given-names></name>; <name><surname>Csordas</surname><given-names>A.</given-names></name>; <name><surname>Dianes</surname><given-names>J. A.</given-names></name>; <name><surname>Fabregat</surname><given-names>A.</given-names></name>; <name><surname>Foster</surname><given-names>J. M.</given-names></name>; <name><surname>Griss</surname><given-names>J.</given-names></name>; <name><surname>Alpi</surname><given-names>E.</given-names></name>; <name><surname>Birim</surname><given-names>M.</given-names></name>; <name><surname>Contell</surname><given-names>J.</given-names></name>; <name><surname>O&#x02019;Kelly</surname><given-names>G.</given-names></name>; <name><surname>Schoenegger</surname><given-names>A.</given-names></name>; <name><surname>Ovelleiro</surname><given-names>D.</given-names></name>; <name><surname>Perez-Riverol</surname><given-names>Y.</given-names></name>; <name><surname>Reisinger</surname><given-names>F.</given-names></name>; <name><surname>Rios</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Hermjakob</surname><given-names>H.</given-names></name>
<article-title>The PRoteomics
IDEntifications (PRIDE) database and associated tools: status in 2013</article-title>. <source>Nucleic Acids Res.</source>
<year>2013</year>, <volume>41</volume><issue>Database issue</issue><fpage>D1063</fpage>&#x02013;<lpage>D1069</lpage>.<pub-id pub-id-type="pmid">23203882</pub-id></mixed-citation></ref></ref-list></back></article>